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ABSTRACT 
 Iron-sulfur proteins comprise one of the most ubiquitous and conserved classes of proteins 
in biology. The diverse functions of iron-sulfur clusters in proteins range from electron transfer to 
redox signaling. The assembly of iron-sulfur clusters in cells requires a complex protein system 
and acquisition of sulfur and iron. While the sulfur source for iron-sulfur cluster assembly is well-
established, the iron source remains elusive. The first part of this work provides new evidence for 
the hypothesis that the conserved iron-sulfur cluster assembly protein IscA may act as the iron 
donor for iron-sulfur cluster assembly.  
 Iron-sulfur clusters in proteins are also vulnerable to reactive oxygen and nitrogen species. 
Indeed, iron-sulfur clusters in proteins can be readily destroyed by nitric oxide (NO) forming 
protein-bound dinitrosyl iron complexes (DNICs). The second part of this work demonstrates that 
iron-sulfur proteins are the major source of protein-bound DNICs found in NO-exposed cells. The 
results reveal new aspects of the molecular mechanism underlying NO cytotoxicity.  
 As dysfunction of iron-sulfur clusters has been implicated in several human diseases, two 
human iron-sulfur proteins have been chosen for functional investigation of their iron-sulfur 
clusters. The first example is Rtel1, a DNA helicase that regulates telomere length. Rtel1 was 
predicted to contain an iron-sulfur cluster, but this was not demonstrated. The third part of this 
work shows that the N-terminal domain of Rtel1 indeed contains a redox active [4Fe-4S] cluster. 
The second example is the mitochondrial outer membrane protein mitoNEET, a recently identified 
target of the type II diabetes drug pioglitazone. The studies show that mitoNEET [2Fe-2S] clusters 
can be readily reduced by biological thiols and human glutathione reductase, and is reversibly 
oxidized by hydrogen peroxide, suggesting that mitoNEET may undergo redox transitions to 
regulate mitochondrial energy metabolism in response to oxidative stress.  
xi 
 
 In summary, the research presented in this dissertation advances our understanding of how 
iron-sulfur clusters may be assembled and how NO modification of iron-sulfur proteins may 
contribute to NO cytotoxicity. The human iron-sulfur proteins Rtel1 and mitoNEET further 
illustrate how iron-sulfur clusters may modulate protein functions via redox transition of their iron-
sulfur clusters in response to oxidative signals. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Diversity of iron-sulfur proteins 
Iron-sulfur proteins comprise a functionally diverse family of proteins found in all forms 
of life. Over 500 unique iron-sulfur proteins have been discovered in various organisms (1), and 
many of these proteins are conserved from prokaryotes to eukaryotes. The iron-sulfur proteins are 
involved in many critical cellular processes, including photosynthesis and respiration, nitrogen 
fixation, DNA synthesis and repair, ribosome biogenesis, lipoic acid and heme biosynthesis, and 
regulation of gene expression (2). Iron-sulfur clusters are believed to be some of the most ancient 
prosthetic groups in proteins, as iron and sulfide coordination was likely favorable in anaerobic 
conditions on the young Earth (3). Minerals containing iron and sulfide may have carried out 
primitive redox reactions on the surfaces of proteins that eventually evolved into catalytic cycles, 
assembling increasingly more complex organic compounds (4,5). Thus, iron-sulfur clusters in 
proteins may be the descendants of the earliest progenitors of life on Earth, and continue to serve 
essential roles in modern organisms. 
An iron-sulfur protein may contain one or more iron-sulfur clusters, which can contribute 
to protein function, maintain structural integrity, or accomplish both. Known iron-sulfur clusters 
are composed of non-heme iron and inorganic sulfide that vary in configuration. The most common 
ones are the 2-iron, 2-sulfur ([2Fe-2S]) and 4-iron, 4-sulfur ([4Fe-4S]) clusters (Figure 1.1), 
although more complex structures exist, such as the [8Fe-7S] cluster of nitrogenase in nitrogen-
fixing bacteria (6). Iron-sulfur clusters are often hosted within proteins by cysteine residues via 
the sulfhydryl R-group of the cysteine(s) coordinating the iron atoms, although other amino acids, 
such as histidine or aspartic acid, can also act as ligands (7,8). 
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1.2 Iron-sulfur cluster biogenesis 
 Iron-sulfur cluster-containing proteins are ubiquitous in biological systems, but the 
mechanism by which these clusters are assembled remains to be fully understood. Iron-sulfur 
clusters are readily assembled in vitro with ferrous iron and sulfide in the presence of a reducing 
agent (9). However, high levels of iron and sulfide in cells are toxic, as free iron can promote the 
generation of free radicals (10) and sulfide has been shown to adversely affect multiple cellular 
functions including oxidative phosphorylation (11). Thus, biological systems have adapted 
complex systems to efficiently assemble iron-sulfur clusters in proteins while maintaining 
physiologically tolerable levels of free iron and sulfide. Like the iron-sulfur proteins themselves, 
iron-sulfur biogenesis is also highly conserved in organisms (2). 
There are three major iron-sulfur cluster assembly systems present in bacteria: ISC, SUF 
and NIF (1). The ISC system is encoded by the iscRSUA-hscBA-fdx-IscX gene cluster which 
represents the housekeeping iron-sulfur cluster assembly activity (12), and is highly conserved 
from bacteria to humans (13). The SUF system, encoded by the sufABCDSE gene cluster (14), is 
activated in response to conditions of oxidative stress or iron starvation (15). The SUF system has 
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been found in bacteria, archaea, and plants (15), and a SUF fusion protein was also recently 
identified in a eukaryotic parasite (16). The NIF system, originally discovered in Azotobacter 
vinelandii (17,18), is encoded by the nifUSVWZM gene cluster and is dedicated to assembling the 
iron-sulfur clusters of nitrogenase (19). 
The iscRSUA-hscBA-fdx-IscX gene cluster in E. coli encodes eight proteins (Figure 1.2) 
(12). The first protein encoded in the ISC gene cluster is IscR, a [2Fe-2S] protein and a 
transcriptional repressor that regulates the ISC gene cluster (20). The [2Fe-2S] clusters will only 
accumulate on IscR when iron-sulfur clusters in the cell are abundant; thus, the repression activity 
of IscR prevents wasteful iron-sulfur cluster assembly. During oxidative stress or iron starvation 
conditions, IscR lacking an iron-sulfur cluster is generated, which de-represses the ISC operon and 
leads to an increase in iron-sulfur cluster assembly (21). In tandem, IscR lacking its iron-sulfur 
cluster will activate the SUF system to stimulate iron-sulfur cluster production in conditions of 
iron starvation or oxidative stress (22). Thus, IscR is a major regulator of iron-sulfur cluster 
assembly in response to iron availability or oxidative stress. 
 IscS, IscU, and IscA comprise the basal iron-sulfur cluster assembly machinery of the ISC 
system. IscS is a cysteine desulfurase that extracts sulfide (S2-) from L-cysteine using a pyridoxal 
phosphate (PLP) cofactor, and generates a persulfide intermediate harbored in IscS which provides 
the sulfur atom for iron-sulfur cluster assembly (23). IscU is a scaffold protein upon which nascent 
iron-sulfur clusters are built (24). IscS first forms a complex with IscU and the sulfur atom from 
IscS is transferred to IscU (25). Iron atoms may be provided for cluster assembly on IscU by the 
proposed iron donor IscA (26), and donation of electrons leads to the assembly of [2Fe-2S] and 
[4Fe-4S] clusters on IscU from the delivered sulfide and iron (27). 
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 The [Fe-S]-loaded IscU then directly transfers its iron-sulfur clusters to recipient proteins, 
and the transfer can be stimulated by the co-chaperones HscB and HscA via a concerted sequence 
of protein interactions (28,29). IscU exists in a disordered (D) state when it does not have an iron-
sulfur cluster, but adopts a structured (S) state upon acquiring an iron-sulfur cluster. D-IscU is 
preferentially bound by IscS for the iron-sulfur cluster assembly, but IscS has weaker affinity for 
the [Fe-S]-loaded S-IscU. Subsequently, S-IscU is competed off of IscS by HscB which delivers 
it to its ATPase co-chaperone, HscA. Hydrolysis of ATP in HscA then facilitates the iron-sulfur 
cluster release from IscU (28). Thus, the HscB / HscA co-chaperones stimulate both the 
dismantling of [Fe-S]-loaded IscU from IscS and the iron-sulfur cluster release from IscU in an 
ATP-dependent mechanism, increasing the rate of iron-sulfur cluster delivery to recipient proteins 
(29). 
Ferredoxin (Fdx) is encoded downstream of the HscB / HscA co-chaperones and contains 
a stable [2Fe-2S] cluster. Although its function is not fully understood, Fdx is predicted to act as 
the electron donor for iron-sulfur cluster assembly on IscU, based on evidence of its association 
with IscS (30,31) and its ability to reductively couple two [2Fe-2S] clusters to form a [4Fe-4S] 
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cluster on IscU (32). Recently, it was demonstrated that ferredoxin-NADP+ reductase can facilitate 
electron donation in iron-sulfur cluster assembly by providing electrons to ferredoxin (33).  
The last protein encoded in the ISC gene cluster is IscX, a small acidic protein recently 
proposed to donate iron for the iron-sulfur cluster assembly process (34). However, IscX has a 
very weak binding affinity for iron (35), and an iscX deletion has only a mild phenotypic effect on 
E. coli cells. On the other hand, IscX was shown to interact with both IscS and IscU (34), 
suggesting that IscX may have functions in the iron-sulfur cluster assembly process that are 
unrelated to iron delivery.  
While much of the ISC system has been described, the protein responsible for delivering 
iron in this process remains unestablished. Before the reports for IscX, the human frataxin and its 
E. coli homolog CyaY were initially posited to be possible iron chaperones (36,37). However, like 
IscX, frataxin and CyaY do not bind significant amounts of iron under physiological reducing 
conditions (26,38). Furthermore, deletion of cyaY in E. coli has no change in phenotype (39). 
Another candidate for iron delivery to the ISC system is IscA. When it was first characterized, 
IscA was hypothesized to be a scaffold protein similar to IscU, as both proteins share a three-
cysteine ligand arrangement capable of binding an iron-sulfur cluster (40,41). It was reported that 
iron-sulfur clusters can be readily assembled on IscA and its paralogs SufA and NifA in vitro 
(42,43), and [Fe-S]-bound IscA can transfer its cluster to recipient proteins (44). However, the 
severe growth deficiency of an iscU deletion in E. coli cannot be suppressed by overexpressing 
IscA (42), and an iscA deletion in E. coli has no change in phenotype (42). Thus, IscA may not act 
as a scaffold protein in parallel with IscU, and [Fe-S]-bound IscA does not appear to have an 
essential role in iron-sulfur cluster assembly. 
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Unlike IscU, the striking feature of IscA is its strong affinity for iron in vitro (45,46) and 
in vivo (26), which supports the hypothesis that IscA could act as an iron donor for the iron-sulfur 
cluster assembly process. Iron binding in IscA is conserved in bacterial (41,47), yeast (48), and 
human homologs (49), as well as its SUF system paralog SufA (42). Furthermore, iron bound to 
IscA and SufA can provide iron for iron-sulfur cluster assembly on IscU (26) and iron-sulfur 
proteins such as dehydratases (50). IscA can also acquire iron from the iron storage protein ferritin 
(51), and the acquired iron can be readily extracted from IscA by L-cysteine (45), suggesting that 
IscA may efficiently procure and deliver iron for iron-sulfur cluster assembly. The proposed 
function of IscA as an iron donor has been summarized in the “USA” model of iron-sulfur cluster 
assembly (52) (Figure 1.3). 
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 IscA and SufA are complementary in function and together they are essential for E. coli 
cells in vivo, as simultaneous deletion of both iscA and sufA results in a null growth phenotype in 
minimal media (50). Furthermore, the iscA-/sufA- E. coli cells fail to assemble [4Fe-4S] clusters in 
proteins when grown in rich media (50). Iron binding in IscA is also inhibited in vivo by copper 
(Cu2+), which likely competes for the same binding site in IscA as iron, and thus impairs the 
assembly of [4Fe-4S] clusters (53). Copper binding in IscA to prevent iron-sulfur cluster assembly 
has been proposed to contribute to copper toxicity in bacteria. Taken together, IscA appears to be 
a major iron donor for iron-sulfur cluster biogenesis. 
In particular, the ISC system has been extensively studied for its implications in human 
disease. One of the earliest links of iron-sulfur assembly to disease was found in Friedreich’s 
ataxia, caused by an inherited mutation in the frataxin gene leading to reduced expression of the 
protein (54). Although its function is not clear, frataxin contributes to efficient iron-sulfur cluster 
assembly in the mitochondria (55), and the protein localizes to the mitochondrion and weakly 
binds iron (56). More recently, an inherited mutation in the gene encoding human IscU was 
associated with mitochondrial myopathy, in which individuals develop severe fatigue after light 
physical exertion (57). There have also been reports that mutation in the human cysteine 
desulfurase, NFS1, causes infant fatality due to the deficiency of iron-sulfur cluster assembly in 
complex II and complex III in mitochondria (58). Mutations in other predicted iron-sulfur cluster 
biogenesis proteins are attributed to mitochondrial dysfunctions affecting the heart and central 
nervous system (58). Thus, the pathology of many debilitating diseases may be clarified by further 
investigation of the ISC system mechanics and its acquisition of iron and sulfur.  
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1.3 Iron-sulfur proteins and oxidative stress 
 The primary function of most iron-sulfur clusters is to transfer electrons. The reversible 
conversion of a ferric (Fe3+) iron to a ferrous (Fe2+) iron in the cluster allows it to participate in a 
wide array of redox reactions. This capability was first observed in ferredoxins in 1962, when they 
were discovered to transfer electrons during nitrogen fixation in an anaerobic bacterium (59) and 
photosynthesis in spinach (60). The ferredoxins are a group of redox active proteins with [2Fe-
2S], [3Fe-4S] and [4Fe-4S] configurations functioning in multiple redox states in cells (61). Aside 
from nitrogen fixation and photosynthesis, electron transfer carried out by iron-sulfur proteins 
occurs in physiological processes including respiration and other metabolic pathways (62). 
Ironically, while many iron-sulfur clusters in proteins participate in electron transfer 
reactions, they are also susceptible to damage from free radicals such as radical oxygen species 
(ROS). The iron centers in the iron-sulfur clusters are readily oxidized by ROS, which could cause 
the iron to be released from the clusters (63). As iron-sulfur proteins often require an intact iron-
sulfur cluster for their function, destruction of the cluster could lead to inactivation of these 
proteins (64), leaving specific biological pathways compromised. Furthermore, free iron released 
from the damaged iron-sulfur clusters may promote the generation of hydroxyl radicals via the 
Fenton reaction (10), which further exacerbates cellular oxidative stress (Figure 1.4). Owing to the 
sensitivity of iron-sulfur clusters to ROS, biological systems have also utilized them as redox 
sensors in response to oxidative stress (65). 
A prevalent ROS species in cells is the superoxide anion (·O2
-). Superoxide is typically 
generated as a byproduct from enzymes such as xanthine oxidase and NAD(P)H oxidase (66), and 
from electron leakage to oxygen during oxidative phosphorylation, particularly from complex I 
(67) and complex III (66) in mitochondria. Superoxide from these sources can be removed from 
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the cell by superoxide dismutase (SOD), which will convert superoxide into hydrogen peroxide 
and molecular oxygen (68). However, extracellular factors including redox cycling agents (69) and 
ultraviolet radiation (70) can promote the production of superoxide and other ROS in cells to 
enhance oxidative stress. Cells will mobilize expression of multiple genes to alleviate oxidative 
stress and to repair the damage inflicted by oxidative stress. 
 In E. coli, excessive superoxide in is sensed by the redox transcription factor SoxR (71). 
SoxR exists as a dimer with a [2Fe-2S] cluster in each protein subunit (72). Under normal 
conditions, the SoxR [2Fe-2S] clusters are in the reduced state and SoxR has no activity (73). 
However, superoxide will oxidize the [2Fe-2S] clusters in SoxR, which induces a conformational 
change; absence of the [2Fe-2S] cluster produces a similar result (74). The activated SoxR will 
then activate the transcription of the gene encoding SoxS, which in turn activates the soxRS regulon 
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for the transcription of over 30 genes utilized in the oxidative stress response (75). Oxidation of 
the SoxR [2Fe-2S] cluster is reversible in vivo, as the dimer with reduced SoxR [2Fe-2S] clusters 
is quickly regenerated after excess superoxide is removed from E. coli cells (76). 
 The [2Fe-2S] cluster in SoxR is one example of many iron-sulfur clusters in proteins that 
sense oxidative stress. Another example is DinG, an E. coli DNA damage-inducible helicase that 
is activated when its [4Fe-4S] cluster is oxidized to facilitate DNA repair in oxidative stress 
conditions (77). The human Regulator of telomere length (Rtel1) (78) is a DNA helicase predicted 
to contain an iron-sulfur cluster, and may also have a redox-dependent helicase activity similar to 
DinG. The human outer mitochondrial membrane protein mitoNEET is thought to function in 
mitochondrial metabolism and contains a [2Fe-2S] cluster (79) that may undergo redox transitions 
to sense the intracellular redox state. Rtel1 and mitoNEET will be discussed further in Section 1.5. 
 
1.4 Iron-sulfur proteins and nitric oxide cytotoxicity 
Iron-sulfur proteins are not only sensitive to reactive oxygen species, but also to nitric oxide 
(NO). NO is a membrane-diffusible free radical that acts as a signaling molecule for many 
biological processes (80). NO is canonically produced by NO synthases (NOS) through the 
conversion of L-arginine to L-citrulline (81), but can also be generated as an intermediate by nitrite 
reductases (82), through a side reaction of molybdoenzymes (83), or by the acidification of nitrite 
(84). In humans, NO serves as a crucial signaling molecule for regulation of the nervous and 
cardiovascular systems (80). Neuronal NOS (nNOS, or NOS-1) was originally identified in the 
brain and serves as an important neurotransmitter (85) with implications in neurodegenerative 
diseases (86). Endothelial NOS (eNOS, or NOS-3) was originally discovered in the endothelial 
tissue, where it generates NO for vasodilation of blood vessels to promote blood flow (85). NO 
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has thus been a promising therapy to protect against ischemia-reperfusion injury (87) or treat 
pulmonary hypertension (88). 
While NO is a crucial signaling molecule at nanomolar concentrations, it becomes 
cytotoxic at micromolar concentrations (89). High concentrations of NO are generated in vivo by 
inducible NO synthase (iNOS, or NOS-2), which is expressed in neutrophils and activated 
macrophages during an immune response (89,90). This heightened production of NO can provide 
a line of defense to kill both bacterial pathogens and tumor cells (89,91). Among the effects of 
cellular damage, NO can irreversibly oxidize thiol groups on proteins (92) and react with 
superoxide to form peroxynitrite (ONOO-), a potent free radical that causes DNA, lipid, and 
protein oxidation (93). 
In bacteria, the primary targets of NO cytotoxicity are the iron-sulfur proteins. Upon 
exposure to NO, the iron-sulfur clusters form dinitrosyl-iron complexes (DNICs) (Figure 1.5), 
composed of two NO molecules bound to a single iron atom (94). This modification process was 
first seen in Clostridium botulinum treated with nitrite and ascorbate, which produced a EPR signal 
at g = 2.04, characteristic of DNICs (95). Indeed, micromolar concentrations of NO inhibit E. coli 
cell growth, which is concomitant with DNIC formation in the cells (96). 
In bacteria, NO cytotoxicity is counteracted by cellular stress responses against NO. SoxR, 
while principally serving as a sensor for superoxide, is activated via NO modification of its [2Fe-
2S] cluster (97). The DNIC-bound SoxR activates the oxidative stress response by the same 
mechanism as the oxidized SoxR after exposure to ROS (74). Recently another [2Fe-2S] protein, 
NsrR, was characterized as a novel redox sensor of NO (98). NsrR acts as a transcriptional 
repressor. Upon NO modification of the [2Fe-2S] cluster, the activated NsrR dissociates from 
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DNA (99). NsrR activation regulates the expression of over 60 genes in bacteria for the NO 
response, including genes encoding NO reductases to detoxify intracellular NO (100). 
 
Counteracting NO cytotoxicity not only requires removal of NO, but also an efficient 
process to remove protein-bound DNICs and subsequently re-assemble new iron-sulfur clusters in 
proteins. DNIC removal can be facilitated by L-cysteine, which results in the decomposition of 
DNICs (96). Oxygen is required for this process in vitro and in vivo. (101). Specifically, the DNIC 
is predicted to transfer from the protein to L-cysteine by thiol exchange, forming L-cysteine-bound 
DNICs. The L-cysteine-bound DNICs are unstable in the presence of oxygen and readily 
decompose, which is detectable by their breakdown to nitrite and ferrous iron (101). The iron-
sulfur cluster repair mechanism following extraction of DNICs remains unclear, but likely involves 
the actions of iron-sulfur cluster assembly machinery (102,103), and a di-iron protein YtfE (104), 
whose expression is regulated by NsrR (105,106). The ISC gene cluster would also be de-repressed 
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due to NO modification of the IscR [2Fe-2S] cluster and its dissociation from DNA, which may 
promote iron-sulfur assembly to repair the NO-modified proteins. Subsequently, the NO-modified 
IscR can also activate the SUF system to provide additional iron-sulfur cluster assembly activity 
(22). 
 
1.5 Key iron-sulfur proteins related to human health 
 As previously mentioned, several diseases are attributed to mutations in proteins involved 
in iron-sulfur cluster biogenesis, such as frataxin (54), IscU (57), and NFS1 (58). In addition, 
diseases have also been attributed to iron-sulfur proteins, including the increased succinate 
dehydrogenase expression in cancer (107), inactivated aconitase in Parkinson’s disease (108), and 
genomic instability due to mutations in DNA helicases (109). Discussed below are two examples 
of iron-sulfur proteins related to human disease. The first example is Regulator of telomere length 
(Rtel1), a predicted iron-sulfur protein and DNA helicase that maintains the integrity of telomeres 
(78). The second example is MitoNEET, a small outer mitochondrial membrane [2Fe-2S] protein 
implicated in mitochondrial metabolism and diabetes. 
 Regulator of telomere length (Rtel1) functions to prevent telomere shortening (78). The 
shortening of telomeres is regarded as one of the primary contributors to aging (110), as loss of 
DNA at telomeres can cause genomic instability and oxidative stress (111). Ironically, telomeres 
are susceptible to loss of DNA at their ends (112). DNA is replicated semi-conservatively on a 
leading and lagging strand of DNA, the latter of which requires RNA primers to synthesize 
Okazaki fragments. The end of telomeric DNA on the lagging strand, however, cannot receive a 
final Okazaki fragment because it requires a primer to precede it for DNA polymerase binding. 
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Thus, replication at telomere ends leaves a 3’ overhang of single-stranded DNA that is vulnerable 
to degradation by nucleases as a result of the “end replication problem” (113,114).  
Fortunately, the vulnerable telomeric DNA resulting from the end replication problem can 
be repaired and / or protected. Human telomeric DNA is composed of TTAGGG repeats, and 
additional nucleotides can be added on the 3’ single-stranded DNA by telomerase, a reverse 
transcriptase with a complementary RNA template of CCCAAUCCC contained within the protein 
structure (115). Additionally, the repetitive telomere DNA sequence can allow the 3’ overhang to 
invade the upstream double-stranded DNA to form a triple-stranded displacement loop (D-loop). 
The D-loop results in the enclosure of a T-loop at the telomere (116) that can be further stabilized 
by a complex of proteins known collectively as shelterin (117). The T-loop and shelterin protect 
the 3’ end of telomeric DNA from nucleolytic degradation, but this protective measure must be 
disassembled for access by telomerase or for another cycle of replication. To facilitate this process, 
the triple-stranded D-loop is unwound by the helicase Rtel1, thereby dismantling the T-loop 
structure for DNA processing to commence. 
Owing to its responsibility in maintaining telomere length and protection, Rtel1 helicase 
activity must be tightly regulated. Studies in mice have demonstrated that deficiency in Rtel1 
activity allows persisting D-loops to be detected by resolvases, which will process the D-loop to 
form telomeric DNA circles (T-circles) and loss of DNA at the telomeric end (118). In contrast, 
overexpression of Rtel1 in mice leads to the excessive dismantling of T-loops, exposing the single-
stranded telomeric ends and increasing telomere fragility (118) (Figure 1.6). 
 Since its discovery, there have been many developments associating dysfunctional Rtel1 
with disease. Rtel1-mediated telomere maintenance in humans was first identified when mutations 
in Rtel1 were linked to Hoyeraal-Hreidarsson syndrome (HHS), a severe form of dyskeratosis 
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congenita characterized by shortened telomeres among other developmental and immune 
symptoms (119,120). Mutations in Rtel1 have been associated with idiopathic pulmonary fibrosis 
 
(121), gliomas (122), and pediatric brain tumors (123), while upregulation of Rtel1 is seen in 
several other cancers (124). In the light of these findings, further biochemical characterization of 
Rtel1 is a necessity.  
 Rtel1 is a member of the superfamily II (SF2) DNA helicases which contain a conserved 
DEAD / DEAH box (125). Human Rtel1 homologs include xeroderma pigmentosum factor D 
(XPD) (126), Fanconi’s anemia complementation group J / BRCA1-associated C-terminal helicase 
(FANCJ / BACH1) (127), and Warsaw breakage syndrome helicase ChlR1 (128). All of these 
proteins, including Rtel1, contain an iron-sulfur cluster binding motif (126,129). E. coli DNA 
helicase DinG, a homolog of XPD and BACH1, also contains a DEAD box and a redox active 
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[4Fe-4S] cluster (130). DinG is activated by oxidative stress conditions, as it becomes active to 
unwind DNA when its iron-sulfur cluster is oxidized; when the cluster is re-reduced, the helicase 
is inactivated (77). Thus, the presence of an iron-sulfur cluster in Rtel1 may implicate a possible 
redox-mediated regulation of its helicase activity that could link oxidative stress to telomere 
maintenance. 
The outer mitochondrial membrane protein mitoNEET has been of great interest in recent 
years due to its possible association with type II diabetes, which has been designated an epidemic 
due to ever-increasing incidences of the disease. By the year 2050, a projected one in three 
Americans will be diabetic (131). Type II diabetes is characterized by a resistance to insulin which 
leads to dysfunctional metabolism and obesity. Due to the metabolic alterations that are a hallmark 
of the disease, particularly hyperglycemia, diabetes has also been linked to the progression of 
cancer growth (132). Furthermore, diabetes exacerbates conditions within cardiovascular (133) 
and neurodegenerative diseases (134). Since the 1990s, a prevalent class of drugs administered to 
combat diabetes symptoms is the thiazolidinediones (TZDs) (135), which can improve insulin 
sensitivity (136). One member of this class, pioglitazone (Figure 1.7), has been prescribed 
worldwide for type II diabetes treatment after exhibiting improvements to both insulin sensitivity 
(137) and control of glucose metabolism (138,139). Pioglitazone treatment has also been shown 
to alleviate metabolic syndrome (140) and dementia brought on by diabetes symptoms (141). 
The well-established binding target of pioglitazone is the peroxisome proliferator-activated 
receptor γ (PPARγ) (136), a nuclear receptor primarily expressed in differentiating adipocytes 
(142). PPARγ is activated upon binding to various fatty acid metabolites, making it a global lipid 
sensor (143). Activated PPARγ regulates genes involved in insulin sensitivity and the homeostasis 
of glucose and fatty acids (144), all of which are affected systems in diabetes. TZDs act as strong 
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activators of PPARγ, which subsequently drives the secretion of insulin sensitizers from 
adipocytes and thus produces the TZD-mediated antidiabetic response (145). Unfortunately, the 
strength of TZDs in activating PPARγ is also predicted to be the cause of the severe side effects, 
including liver damage (146), heart failure (147), and possibly bladder cancer (148). 
 
Furthermore, some effects seen from TZDs originated from mitochondria and were 
unrelated to the activation of PPARγ (149). In 2004, tritium-labeled pioglitazone detected 
mitoNEET as an additional TZD binding target (150), and upon further characterization 
mitoNEET was found to possess a [2Fe-2S] cluster (79). Due to its presence in mitochondria and 
its increased expression in differentiating adipocytes, mitoNEET is speculated to play a role in 
both lipid metabolism and insulin sensitivity (151). The binding of pioglitazone to mitoNEET 
suggests that some antidiabetic effects observed from TZDs may be a direct result of altering 
mitoNEET function. However, the exact function of mitoNEET in vivo remains unclear. 
Genetic studies have suggested that mitoNEET is critical in regulating iron homeostasis 
(151,152) and energy metabolism (150,151,153). Decreased levels of mitoNEET in mouse 
adipocytes led to an increased uptake of iron, resulting in enhanced oxidative phosphorylation. As 
a consequence, the increased metabolism attenuated weight gain in these mice when fed a high-fat 
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diet (153). In contrast, mitoNEET enrichment in adipocyte mitochondria inhibited iron import, 
which led to decreased oxidative phosphorylation, lipid accumulation in adipocytes, and obesity 
(151). Thus, although its function remains to be determined, the mitoNEET may be involved in 
regulating mitochondrial metabolism. 
MitoNEET resides on the outer mitochondrial membrane as a dimer, and hosts the [2Fe-
2S] cluster via a ligand arrangement of three cysteine and one histidine residues (153,154). Due to 
this unique ligand arrangement the cluster is particularly labile, with its stability influenced by pH 
(155), inter-domain interactions (156,157) and the hydrogen bond network (158), as well as 
binding of NADP+ or NADPH (155,159), intracellular zinc (160), resveratrol-3-sulfate (161), and 
pioglitazone (162). Modulation of the [2Fe-2S] cluster by these factors led to the initial hypothesis 
of mitoNEET as an iron-sulfur cluster transfer protein. Such a hypothesis was exciting, as it 
implied a novel pathway for mitochondrial iron-sulfur clusters to reach cytosolic proteins. Indeed, 
mitoNEET is capable of transferring its [2Fe-2S] cluster to apo-ferredoxin (159,163), and this 
transfer activity can be inhibited by pioglitazone (163) or NADPH binding (159). It was also 
demonstrated that mitoNEET can donate its [2Fe-2S] cluster for the repair of the [4Fe-4S] cluster 
on iron regulatory protein 1 (IRP-1) to regenerate its active aconitase form (152). This suggested 
that mitoNEET contributes to iron homeostasis, which supported the mouse genetic studies (151). 
However, all of these transfer processes occur only when the mitoNEET [2Fe-2S] clusters are 
oxidized. Furthermore, the rate of mitoNEET [2Fe-2S] cluster transfer is relatively slow, acting on 
a time scale of hours (159,163). Thus, the conditions under which mitoNEET can transfer its [2Fe-
2S] cluster is greatly restricted to conditions that may not be deemed physiological. 
Alternatively, mitoNEET may act as a redox sensor. The mitoNEET [2Fe-2S] cluster 
possesses an unusually high redox midpoint potential (Em), suggesting that electron transfer to the 
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cluster may be favorable in physiological conditions. The redox midpoint potential at pH 7.0 (Em7) 
of the mitoNEET [2Fe-2S] cluster is ~0 millivolts (162,164). The intracellular environment is 
normally in the reduced state (165), with the redox potential of eukaryotic cells estimated at 
approximately -325 mV at pH 7.0 (166). Thus, mitoNEET [2Fe-2S] clusters may exist in the 
reduced state in vivo, and the unique histidine ligand of the mitoNEET [2Fe-2S] cluster is 
responsible for its unusually high redox midpoint potential (162). The redox characteristics of 
mitoNEET are reminiscent of E. coli SoxR, a dimer with [2Fe-2S] clusters in the reduced state in 
vivo that acts as a redox sensor of oxidative stress (73,97). In the context of diabetes, it is interesting 
to speculate that mitoNEET acts as a redox sensor, as mitoNEET has numerous reported protein 
binding partners (149,167-170) that could be regulated by this sensing activity. The binding of 
pioglitazone causes a shift in the redox midpoint potential of the mitoNEET [2Fe-2S] cluster from 
~0 to -100 mV (162), which may interfere with the redox transitions of the cluster and thus 
modulate the signaling capabilities of mitoNEET. 
 
1.6 Statement of research objectives 
Iron-sulfur cluster biogenesis has been extensively studied due to its role in assembling 
some of the most functionally diverse and widely conserved cofactors known. However, critical 
features of the assembly process still remain unclear, including the source of iron for incorporation 
into the clusters. IscA possesses a unique and strong iron binding affinity, and IscA can deliver 
iron for the assembly process in vitro. The first aim of this work is to correlate the iron binding 
ability in IscA with its function in cells, demonstrating that iron binding in IscA is essential to 
iron-sulfur cluster assembly in vivo. 
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The redox properties of iron-sulfur proteins allows them to serve in diverse cellular 
processes, including electron transfer. Ironically, iron-sulfur clusters are a susceptible target of free 
radicals such as nitric oxide (NO), which can destroy the clusters to generate dinitrosyl-iron 
complexes and contribute to NO cytotoxicity. Although NO modification of iron-sulfur clusters is 
well-characterized in vitro, it is unclear whether they contribute to DNICs observed in vivo, as 
DNICs may also be produced by thiols or other proteins in combination with iron. The second aim 
of this work is to identify the primary source of DNICs formed in E. coli cells under nitric oxide 
stress. 
 Iron-sulfur proteins play essential roles in DNA synthesis and repair. Regulator of telomere 
length (Rtel1) is a DNA helicase responsible for the maintenance of telomeric DNA, which is 
vulnerable to nucleolytic degradation and shortening with each replication cycle. Rtel1 is a 
member of the superfamily II helicases, all of which share an iron-sulfur cluster binding domain. 
Rtel1 is implicated in a number of diseases, and although it has been investigated genetically, the 
biochemical characterization of Rtel1 is still in its beginnings. The third aim of this work is to 
confirm the presence of an iron-sulfur cluster in Rtel1 and characterize the role of the cluster as it 
correlates to protein function. 
 The recently discovered [2Fe-2S] mitoNEET is a binding target of the broadly-prescribed 
type II diabetes drug pioglitazone, and genetic studies have demonstrated its importance in 
modulating iron homeostasis and metabolism in the mitochondria. The precise function of 
mitoNEET, however, is unclear. Because of the unique redox properties of its [2Fe-2S] cluster, 
mitoNEET may function as a redox sensor. The fourth aim of this work is to investigate 
physiological redox transitions of mitoNEET [2Fe-2S] clusters, and how these transitions are 
affected by the binding of the type II diabetes drug pioglitazone to mitoNEET. 
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CHAPTER 2 
IRON BINDING ACTIVITY IS ESSENTIAL FOR THE FUNCTION OF ISCA 
IN IRON-SULFUR CLUSTER BIOGENESIS 1 
 
2.1 Introduction 
Throughout evolution, iron-sulfur clusters have become integral parts of diverse 
physiological processes including photosynthesis, nitrogen fixation, sugar metabolism, cofactor 
biogenesis, RNA modification and translation, DNA replication and repair, and gene expression 
regulation (1-4). While iron-sulfur clusters can be assembled in proteins in vitro with ferrous iron 
and sulphide, iron-sulfur cluster assembly in vivo requires a group of dedicated proteins that are 
conserved from bacteria to humans (5). In Escherichia coli, the proteins encoded by a gene cluster 
iscSUA-hscBA-fdx are primarily responsible for iron-sulfur cluster assembly under normal growth 
conditions (5). The homologs of six of the proteins encoded by iscSUA-hscBA-fdx have been 
identified in eukaryotic organisms (2). Among them, IscS is a cysteine desulfurase that catalyzes 
desulfurization of L-cysteine (6-8) and provides sulfur for iron-sulfur cluster assembly in a scaffold 
protein IscU (9-11). IscU in turn transfers the assembled clusters to target proteins (12,13). IscA 
has been characterized as an alternative scaffold or intermediate carrier for iron-sulfur cluster 
assembly (14,15). A comprehensive characterization of iron-sulfur cluster binding in an IscA 
homolog NifIscA from Azotobacter vinelandii has recently been reported (16). Two heat shock 
cognate proteins, HscB and HscA, have specific interactions with IscU (17) and promote the 
transfer of assembled clusters from IscU to target proteins in an ATP-dependent reaction (18,19). 
                                                 
1 This chapter previously appeared as: Landry, A. P., Cheng, Z., and Ding, H. (2013) Iron binding 
activity is essential for the function of IscA in iron-sulphur cluster biogenesis. Dalton transactions 
42, 3100-3106. Modified and reprinted by permission of the Royal Society of Chemistry. 
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Ferredoxin, which contains a stable [2Fe-2S] cluster (20), is likely involved in the reductive 
formation of a [4Fe-4S] cluster in scaffold protein IscU (21,22). 
While the sulfur donor for iron-sulfur cluster assembly has been well established (6-8), the 
iron donor(s) remains largely elusive. Frataxin, a mitochondrial protein that is linked to 
neurodegenerative disease Friedreich's ataxia (23), has previously been characterized as a likely 
iron donor for iron-sulfur cluster assembly (24,25). Deficiency of frataxin results in diminished 
activity of iron-sulfur enzymes in yeast cells (26), and frataxin has physical interactions with iron-
sulfur cluster assembly protein IscU (27-29), the IscU / IscS complex (30,31), and with the iron-
sulfur enzyme aconitase in mitochondria (32). However, frataxin has a weak iron binding activity 
with an iron binding constant of 4 to 55 μM (24,33,34). Such a low iron binding affinity may 
preclude frataxin from binding any significant amounts of iron in mitochondria under normal 
physiological conditions. Furthermore, deletion of frataxin homolog CyaY in E. coli does not 
affect iron-sulfur cluster biogenesis (35), and frataxin-deficient yeast cells can be rescued by either 
expressing ferritin (36) or vacuolar iron transporter CCC1 (37). In fact, scavenging H2O2 can 
effectively restore iron-sulfur enzyme activities in a Drosophila model of Friedreich's ataxia (38). 
Thus, the primary function of frataxin could be to maintain iron homeostasis under oxidative stress 
(39,40) or to modulate overall iron-sulfur cluster assembly in cells (30,31). More recently, the 
protein IscX, which lies downstream of the iscSUA-hscBA-fdx operon, has been proposed to be an 
iron donor for iron-sulfur cluster assembly (41). Similar to frataxin, however, IscX has only a weak 
binding affinity for iron (42,43). Furthermore, deletion of IscX in E. coli has only a mild effect in 
iron-sulfur cluster assembly (44), suggesting that it may have other functions in the assembly 
process unrelated to iron delivery. 
38 
 
In previous studies, we reported that unlike other iron-sulfur cluster assembly scaffold 
proteins such as IscU, IscA has a strong iron binding activity with an apparent iron association 
constant of 1.0 x 1019 M-1 (45-49). A similar strong iron binding activity has been observed for the 
IscA homolog from humans (50), yeast cells (51), and A. vinelandii NifIscA (52). In this study, we 
present new evidence showing that among the primary iron-sulfur cluster assembly proteins, IscA 
is unique in binding iron, and that the tightly-bound ferric iron in IscA can be readily extruded by 
L-cysteine, followed by reduction to ferrous iron for iron-sulfur cluster assembly. Site-directed 
mutagenesis studies show that the iron-binding activity is crucial for the physiological function of 
IscA in iron-sulfur cluster biogenesis. 
 
2.2 Materials and Methods 
Protein preparation 
The iron-sulfur cluster assembly proteins IscS, IscU, IscA, HscB, and HscA from E. coli 
were prepared as described previously (47). The IscA mutant in which tyrosine 40 was substituted 
with phenylalanine (Y40F) was constructed using the site-directed mutagenesis kit (Stratagene). 
The mutation of gene iscA in the cloned plasmid was confirmed by direct sequencing. Human 
frataxin was subcloned from plasmid pETHF2(53) to expression plasmid pET28b+ and prepared 
as described in (50). The E. coli frataxin homolog CyaY was prepared as described in (48). The 
protein concentration was determined from the absorption peak at 260 nm or 280 nm using the 
previously-published extinction coefficient for each protein. 
In vitro iron binding and iron-sulfur cluster assembly in IscA 
 For the iron binding experiments, each of purified iron-sulfur cluster assembly proteins (50 
μM in monomer) was incubated with Fe(NH4)2(SO4)2 (50 μM) and sodium citrate (5 mM) in buffer 
containing NaCl (200 mM), and Tris (20 mM, pH 8.0) in the presence of dithiothreitol (2 mM) at 
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room temperature for 20 minutes, followed by passage through a HiTrap desalting column. Total 
iron content in re-purified protein samples were determined using an iron indicator FerroZine as 
described in (54). For iron-sulfur cluster assembly, purified IscA was incubated with IscS (0.5 
μM), Tris (20 mM, pH 8.0), NaCl (200 mM), Fe(NH4)2(SO4)2 (50 μM), and dithiothreitol (2 mM) 
at 37°C for 5 minutes under anaerobic conditions. L-cysteine (1 mM) was then added to initiate 
the iron-sulfur cluster assembly reaction. The amount of iron-sulfur clusters assembled in protein 
was monitored in a Beckman DU-640 UV-visible spectrophotometer. 
EPR measurements 
EPR (electron paramagnetic resonance) spectra were recorded at X-band on a Bruker ESR-
300 EPR spectrometer using an Oxford Instruments ESR-9 flow cryostat. The routine EPR 
conditions were: microwave frequency, 9.45 GHz; microwave power, 10 mW; modulation 
frequency, 100 kHz; modulation amplitude, 2.0 mT; temperature, 10 K; receive gain, 1.0 x 105.  
In vivo activity assay of the IscA Y40F mutant 
For the in vivo activity of the IscA Y40F mutant, the gene encoding Y40F was cloned into 
a plasmid pBAD (Invitrogen). The constructed plasmid pBAD/Y40F was introduced into an E. 
coli mutant in which gene iscA and its paralog sufA were in-frame deleted (55). The E. coli iscA-
/sufA-double mutant was viable in rich LB medium, but had a null-growth phenotype in M9 
minimal medium under aerobic conditions (55). The E. coli iscA-/sufA- double mutant strain 
containing pBAD/iscA and pBAD served as a positive and negative control, respectively. 
 
2.3 Results 
IscA has a unique iron binding activity among the iron-sulfur cluster assembly proteins 
 To explore the iron binding activity of the primary iron-sulfur cluster assembly proteins 
encoded by the gene cluster iscRSUA-hscBA-fdx-iscX from E. coli (5), we expressed these proteins 
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in wildtype E. coli cells grown in LB medium. Each protein was purified to a single band on the 
SDS-PAGE gel. IscX iron binding was reported previously (42,43), and because IscR and 
ferredoxin contain [2Fe-2S] clusters (20, 66), these proteins were not included for the iron binding 
analysis. Among the other assayed iron-sulfur cluster assembly proteins encoded by iscRSUA-
hscBA-fdx-iscX, only purified IscA contained 0.09 ± 0.02 iron atoms per IscA dimer (Figure 2.1 
A). No acid-labile sulfur was detectable in purified IscA, indicating that purified IscA did not 
contain any significant amounts of iron-sulfur clusters. 
 
 The iron binding activity of purified iron-sulfur cluster assembly proteins was also 
analyzed in vitro. Each purified protein was incubated with freshly-prepared ferrous iron in the 
presence of dithiothreitol under aerobic conditions, followed by re-purification of the protein. 
Figure 2.1 B shows that while the iron content in IscA increased to 1.05 ± 0.10 iron atoms per IscA 
dimer after incubation with an equivalent amount of ferrous iron (relative to protein monomer), 
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the iron content in other proteins was less than 0.1 iron atoms per protein dimer, demonstrating 
that IscA has a unique iron binding activity. 
Until recently, the only other candidate proposed for the iron donor to iron-sulfur cluster 
assembly in scaffold protein IscU was frataxin and its bacterial homolog CyaY (24,25). To explore 
the iron binding activity of frataxin / CyaY in vitro under the same experimental conditions, 
purified E. coli CyaY and human frataxin were incubated with an equivalent amount of ferrous 
iron in the presence of dithiothreitol. Very little or no iron binding is found in re-purified CyaY 
and human frataxin (data not shown), suggesting that unlike IscA from E. coli (45) and humans 
(50), frataxin / CyaY has a very weak iron binding activity in the presence of dithiothreitol. 
The ferric iron in IscA is extruded by L-cysteine, followed by reduction to ferrous iron  
To access the iron in IscA for iron-sulfur cluster biogenesis, the iron stored in the protein 
must be quickly released when there is such a demand. Previously, we reported that L-cysteine, 
but not other related biological thiols including N-acetyl-L-cysteine or reduced glutathione, can 
efficiently release iron from the iron-bound IscA (56). However, the mechanism underlying the L-
cysteine-mediated iron release from IscA was not clear. 
Iron-bound IscA has an unusual EPR signal at g = 4.3 and 6.0 (45). The signal is completely 
eliminated upon removal of iron from the protein, and is fully restored after reconstitution with 
iron, indicating that the EPR signal represents iron binding in IscA (45). Interestingly, a similar 
EPR signal was previously reported for the S = 3/2, reduced [4Fe-4S] cluster in proteins such as 
nitrogenase (57) and 2-hydroxyglutaryl-CoA dehydratase (58). While further biophysical studies 
will be important to determine the spin state of the iron center in E. coli IscA, recent optical and 
magnetic spectroscopic characterization of NifIscA, an IscA homolog from A. vinelandii, provided 
comprehensive and convincing evidence for the assignment of the iron site in NifIscA to a ferric 
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iron in an unusual rhombic spin S = 3/2 state (52). The EPR spectra of the iron-bound NifIscA from 
A. vinelandii (52) and the iron-bound IscA from E. coli (45) are essentially the same. Furthermore, 
the iron center in both E. coli IscA and NifIscA is redox active, as the EPR signal at g = 4.3 and 6.0 
disappears when the iron center in IscA is reduced by sodium dithionite (45,52). To follow the 
process of the L-cysteine-mediated iron release from IscA, we used EPR to monitor the redox state 
of the iron center in IscA when the iron-bound IscA was incubated with L-cysteine under aerobic 
conditions. At different time points, aliquots were taken from the incubation solution after addition 
of L-cysteine for EPR measurements. 
Figure 2.2 shows that upon addition of L-cysteine, the EPR signal at g = 4.3 and 6.0 of the 
iron-bound IscA is quickly replaced with a new EPR signal at g = 4.3, representing “free” ferric 
iron in solution (59). After further incubation (over 20 minutes), the newly-formed EPR signal at 
g = 4.3 is gradually decreased, indicating that the “free” ferric iron is reduced to the EPR-silent 
ferrous iron. As a control, incubation of the iron-bound IscA with N-acetyl-L-cysteine or reduced 
glutathione does not affect the EPR signal at g = 4.3 and 6.0 of the iron-bound IscA (data not 
shown). On the other hand, D-cysteine has the same activity as L-cysteine in releasing iron from 
IscA (56), suggesting that the redox property, but not stereochemistry, of L-cysteine is responsible 
for the iron release from IscA.  
The transition of the EPR signal of the iron-bound IscA from g = 4.3 and 6.0 to g = 4.3 
upon addition of L-cysteine indicates that the L-cysteine-mediated iron release from IscA may 
have two distinctive steps. In the first step, L-cysteine extrudes ferric iron from IscA via ligand 
exchange to form the L-cys-Fe3+-IscA and / or the L-cys-Fe3+ complex which contributes to the 
observed EPR signal at g = 4.3 (Figure 2.2). In the second step, the L-cys-Fe3+-IscA and / or L-
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cys-Fe3+ complex is reduced by L-cysteine to the EPR-silent ferrous iron, which will be accessible 
for iron-sulfur cluster biogenesis (47). 
 
Mutation at residue tyrosine 40 to phenylalanine diminishes the iron binding activity of IscA  
From the crystal structure, E. coli IscA is a homodimer with the three conserved cysteine 
residues (Cys 35, Cys 99 and Cys 101) projected to form a “cysteine pocket” between two 
monomers (60,61). Mutation of any of the three conserved cysteine residues to serine produced 
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IscA mutant proteins that have a diminished iron binding activity (62) and are inactive in E. coli 
cells (55). However, because the cysteine residues may accommodate either a mononuclear iron 
or iron-sulfur cluster in IscA, mutation of cysteine residues would have affected both the iron and 
iron-sulfur cluster binding in the protein. 
Among the amino acid residues that are in the vicinity of the putative iron binding site in 
IscA dimer, tyrosine 40 is highly conserved and located in the interface between two IscA 
monomers (Figure 2.3). Unlike other nearby conserved residues that form a hydrophobic packing 
between IscA monomers (60), the hydroxyl group of tyrosine 40 may act as a possible oxygenic 
ligand for iron binding in IscA dimer (52). 
 
To explore the role of tyrosine 40 in the iron binding and iron-sulfur cluster binding of 
IscA, we constructed an IscA mutant in which tyrosine 40 was substituted with phenylalanine 
(Y40F). The IscA mutant Y40F protein was purified and incubated with increasing concentrations 
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of ferrous iron, followed by re-purification of the protein. Figure 2.4 shows that unlike wildtype 
IscA, the absorption peak at 315 nm of the iron binding in IscA mutant Y40F is only slightly 
increased  after  incubation  with  ferrous  iron  in  the  presence  of  dithiothreitol. The iron content  
 
analyses revealed that after incubation with two-fold excess of iron per protein dimer, the ratio of 
iron to the wildtype IscA dimer is 1.05 ± 0.10, while the ratio of iron to the IscA mutant Y40F 
dimer is less than 0.15. The wildtype IscA and Y40F mutant proteins after reconstitution with a 
two-fold excess of iron were re-purified, concentrated, and subjected to EPR measurements. While 
wildtype IscA has a typical EPR spectrum of the iron-bound protein with g = 4.3 and 6.0, IscA 
mutant Y40F only has a small EPR signal at g = 4.3 region (data not shown). In the light of recent 
publication on the iron binding property of NifIscA (52), it would be interesting to determine 
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whether tyrosine 40 actually provides the oxygenic ligand for the iron binding in IscA. Regardless, 
the results shown in Figure 2.4 clearly demonstrate that mutation of tyrosine 40 severely 
diminishes the iron binding activity of E. coli IscA in vitro. 
  
 Next, we explored the iron-sulfur cluster binding activity of the wildtype IscA and IscA 
mutant Y40F. Purified IscA and IscA mutant Y40F proteins were incubated with ferrous iron, L-
cysteine, and a catalytic amount of IscS in the presence of dithiothreitol under anaerobic 
conditions. After 20 minutes incubation, the iron-sulfur cluster assembly in IscA was analyzed. 
Figure 2.5 shows that like wildtype IscA, the Y40F mutant retains iron-sulfur cluster binding 
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activity, suggesting that mutation of tyrosine 40 does not significantly affect iron-sulfur cluster 
assembly in IscA in vitro. 
IscA mutant Y40F is inactive in E. coli cells 
E. coli has at least two IscA paralogs: ErpA and SufA. ErpA, which maps at a distance 
from any iron-sulfur cluster assembly-related genes, has been characterized as a dedicated scaffold 
for maturation of several iron-sulfur enzymes (63-65) and transcription factors (66). SufA, on the 
other hand, is a member of second iron-sulfur cluster assembly gene cluster sufABCDSE in E. coli 
(67). Purified SufA, like IscA, has a strong iron binding activity and provides iron for iron-sulfur 
cluster assembly in IscU in vitro (55). While deletion of IscA or SufA in E. coli cells only has a 
mild effect on cell growth, deletion of both IscA and SufA results in a null-growth phenotype in 
M9 minimal medium under aerobic conditions (55,68). Re-introducing IscA or SufA restores the 
cell growth of E. coli iscA-/sufA- double mutant (55,69), suggesting that IscA and SufA are 
complementary to each other. 
To determine the in vivo activity of the IscA mutant Y40F, a plasmid expressing Y40F was 
introduced into the E. coli iscA-/sufA- double mutant cells. The cells were inoculated in M9 
minimal medium and grown under aerobic conditions. Figure 2.6 shows that unlike wildtype IscA, 
the Y40F mutant failed to restore the cell growth of the E. coli iscA-/sufA- double mutant in M9 
minimal medium under aerobic conditions. Since the IscA mutant Y40F has a diminished iron 
binding activity but retains the iron-sulfur cluster binding activity, we propose that iron binding 
activity is essential for the physiological function of IscA in iron-sulfur cluster biogenesis, while 
the possible iron-sulfur cluster binding activity may be dispensable. 
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2.4 Discussion 
Phylogenomic analyses revealed that IscA is highly conserved from prokaryotic to 
eukaryotic organisms (70). In A. vinelandii, depletion of IscA produces a null-growth phenotype 
in modified Burks minimal medium under elevated oxygen conditions (71). In E. coli, deletion of 
IscA and its paralog SufA results in a mutant that fails to grow in M9 minimal medium under 
aerobic conditions (55,68). In S. cerevisiae, depletion of IscA homologs leads to iron accumulation 
in mitochondria and dependency on lysine and glutamate in media (72). In human Hela cells, RNAi 
knockdown of IscA homolog results in decreased activities of iron-sulfur enzymes in both 
mitochondria and cytosol (73). Evidently, IscA has a crucial role for iron-sulfur cluster biogenesis, 
especially under aerobic conditions. However, the physiological function of IscA remains 
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controversial. One hypothesis stated that IscA acts as an alternative scaffold protein or 
intermediate carrier for iron-sulfur cluster biogenesis, as IscA is able to bind an iron-sulfur cluster 
and transfer the cluster to target proteins (14-16). However, unlike other scaffold proteins such as 
IscU (9), IscA has a strong iron binding activity with a maximum binding of one iron per IscA 
dimer (45-49). Recent spectroscopic characterization of NifIscA from A. vinelandii confirms that 
NifIscA is able to bind one iron per dimer, and that the iron center in IscA is in an unusual 
intermediate S = 3/2 spin state (52). The results presented in this study provide new evidence for 
the hypothesis that IscA is a bona fide iron binding protein.  
Among the primary iron-sulfur cluster assembly proteins encoded by the gene cluster 
iscRSUA-hscBA-fdx-iscX (5) and the putative iron donor frataxin / CyaY (24,25), only IscA has a 
strong binding activity for mononuclear iron in the presence of dithiothreitol. Furthermore, the 
ferric iron center tightly bound in IscA can be readily extruded by L-cysteine, followed by 
reduction to ferrous iron. Additional studies further reveal that mutation at tyrosine 40, a possible 
oxygenic ligand for the iron binding in IscA (52), diminishes iron binding activity but retains iron-
sulfur cluster binding activity of IscA. Genetic complementation studies show that Y40F is 
inactive in vivo, suggesting that the iron binding activity is essential for the physiological function 
of IscA. Collectively, the results support the hypothesis that IscA may act as an iron donor for 
iron-sulfur cluster biogenesis. Nevertheless, since IscA can also bind iron-sulfur clusters (14,15) 
and transfer the assembled clusters to target proteins (16), the role of IscA as an alternative scaffold 
protein cannot be excluded. Perhaps the iron binding in IscA could be the initial step for iron-
sulfur cluster assembly either in IscA, or in other scaffold proteins such as IscU (47). Evidently, 
additional experiments are required to illustrate the role of IscA in iron-sulfur cluster biogenesis. 
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It is worth pointing out that IscA / SufA is dispensable for cell growth of E. coli in M9 
minimal medium under anaerobic conditions (49). Interestingly, most anaerobic organisms do not 
contain an IscA homolog and almost all aerobic organisms contain at least one copy of IscA in 
their genomes (70). It may be envisioned that under anaerobic conditions, intracellular “free” iron 
is more readily available for iron-sulfur cluster biogenesis and IscA is unnecessary. In aerobic 
organisms, however, functional IscA would be required to recruit intracellular iron and deliver 
iron or iron-sulfur clusters for iron-sulfur cluster biogenesis under aerobic conditions.  
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CHAPTER 3 
IRON-SULFUR PROTEINS ARE THE MAJOR SOURCE OF PROTEIN-BOUND 
DNICS FORMED IN E. COLI CELLS UNDER NITRIC OXIDE STRESS 2 
 
3.1 Introduction 
Nitric oxide (NO) is produced from L-arginine by NO synthases (1) or from nitrite by 
chemical reduction (2) or nitrite reductases (3), and has diverse physiological functions. At low 
concentrations (nM), NO acts as a signaling molecule for intercellular communication in neuronal 
and cardiovascular systems (4). At high concentrations (µM), NO becomes a powerful weapon 
that kills pathogenic bacteria and cancer cells (5). Among the cellular targets of NO cytotoxicity 
are proteins that contain iron-sulfur clusters (6-14). Iron-sulfur proteins are involved in a broad 
range of physiological processes, from energy metabolism to DNA synthesis and repair (15,16). 
In vitro studies have shown that NO can directly react with iron-sulfur clusters (17,18) forming 
protein-bound dinitrosyl-iron complexes (DNICs) (19-27). The NO-mediated formation of 
protein-bound DNICs has also been observed in bacterium Clostridium botulinum where NO is 
produced from nitrite reduction (28), in activated macrophages where NO is produced by inducible 
NO synthase (29,30), in tumor cells co-cultured with activated macrophages (31), in post-operative 
day-4 allografts (32), in the gastro-esophageal junction (11), and in cultured mammalian cells 
treated with various NO donors (33-36). When Escherichia coli cells are exposed to pure NO gas 
at concentrations (μM) that emulate pathophysiological production of NO (37,38), a large number 
of iron-sulfur proteins are modified forming protein-bound DNICs (12), suggesting that iron-sulfur 
proteins are one of primary targets of NO cytotoxicity (8,10,12).  
                                                 
2 This chapter previously appeared as: Landry, A. P., Duan, X., Huang, H., and Ding, H. (2011) 
Iron-sulfur proteins are the major source of protein-bound dinitrosyl iron complexes formed in 
Escherichia coli cells under nitric oxide stress. Free radical biology & medicine 50, 1582-1590. 
Modified and reprinted with permission of Elsevier. 
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NO can also react with small molecule thiols and ferrous iron to form thiol-bound DNICs, 
which have a similar electron paramagnetic resonance (EPR) signal at g = 2.04 as protein-bound 
DNICs (39-41). However, the existence of small molecule thiol-bound DNICs has never been 
demonstrated in any living cells (42,43), likely because small molecule thiol-bound DNICs are not 
stable in aqueous solution (e.g. the half-life time of the cysteine-bound DNIC is less than 1 minute) 
(27,44) or are quickly exported by the multidrug resistance-associated protein-1 (34). The only 
stable glutathione-bound DNICs in cells are found to be associated with glutathione S-transferases, 
a potential protection mechanism against excess NO (43). More recently, it has been postulated 
that large molecular mass-bound DNICs, instead of small molecule thiol-bound DNICs, are 
formed in cultured mammalian cells under NO stress (35,36). However, the identities of large 
molecular mass-bound DNICs have not been defined (35,36). 
In this study, we combine molecular genetics and biophysics approaches and demonstrate 
that iron-sulfur proteins are the major source of large molecular mass-bound DNICs formed in E. 
coli cells under NO stress. Expression of recombinant iron-sulfur proteins almost doubles the 
amount of protein-bound DNICs formed in E. coli cells under NO stress. Deletion of the iron-
sulfur cluster assembly proteins IscA and SufA to block the [4Fe-4S] cluster assembly (45,46) 
largely eliminates the NO-mediated formation of protein-bound DNICs in E. coli cells, suggesting 
that iron-sulfur clusters, but not “free” iron, are mainly responsible for the NO-mediated formation 
of protein-bound DNICs. Furthermore, depletion of the “chelatable iron pool” in the wildtype E. 
coli cells effectively removes iron-sulfur clusters from proteins and concomitantly diminishes the 
NO-mediated formation of protein-bound DNICs, suggesting that iron-sulfur clusters in proteins 
constitute at least part of the “chelatable iron pool” in cells. The physiological relevance of the 
NO-mediated modification of iron-sulfur proteins will be discussed.  
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3.2 Materials and Methods 
Gene cloning and protein purification 
The genes encoding E. coli aconitase B (47), dihydroxyacid dehydratase (IlvD) (48), the 
redox transcription factor SoxR (22), the heat shock cognate protein HscA (49), and the single-
stranded DNA-binding protein SSB (50) were cloned into pET28b+ (Novagen) or pBAD 
(Invitrogen) expression vectors as described previously (25). Cloned genes were confirmed by 
direct sequencing (LSU Gene Lab). Recombinant proteins were expressed in E. coli strain 
BL21(DE3), MC4100, or the iscA-/sufA- double mutant (45) cells, and the protein expression was 
confirmed by SDS-PAGE analyses. The protein expression clones of E. coli ASKA library (51) 
were also used for the expression of IlvD, SoxR, HscA, and SSB. All protein purification solutions 
were purged with pure argon gas before use. Recombinant proteins were purified as described in 
(25), and the purity of purified proteins was over 95% judging from SDS-PAGE analyses. 
NO exposure of E. coli cells 
Overnight E. coli cells containing protein expression plasmid were diluted 1:100 in freshly 
prepared LB (Luria-Bertani) medium and incubated at 37oC with aeration (250 rpm) for 3 hours, 
followed by protein induction with IPTG (100 μM) or arabinose (0.02%) for an additional 2 to 3 
hours. For the iscA-/sufA- double mutant, the cells were grown for 8 hours before protein induction 
with arabinose for an additional 4 hours (45). Both the wildtype and mutant cells were harvested 
and re-suspended in M9 minimal medium to an O.D. at 600 nm of 4.0-6.0. Chloramphenicol (34 
μg/mL) was added to the harvested E. coli cells to block new protein synthesis. Cells were then 
purged with pure argon gas before being treated with the NO-releasing reagent diethylamine 
NONOate (Cayman Chemical) at 37°C for 5 minutes. Diethylamine NONOate was dissolved in 
buffer containing Tris (20 mM, pH 10.5), and the concentration of the NONOate was determined 
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from the absorption peak at 250 nm using an extinction coefficient of 6.5 mM-1cm-1. Diethylamine 
NONOate releases 1.5 moles of NO at a half-life time of 2 minutes at 37°C (pH 7.4). Released NO 
was monitored using an NO electrode (World Precision Instruments). The Silastic tubing NO 
delivery system (52) was also used for the NO exposure of E. coli cells as described previously 
(12). Similar results were obtained when E. coli cells were exposed to NO using either 
diethylamine NONOate or the Silastic tubing NO delivery system.  
Depletion of the “chelatable iron pool” in E. coli cells 
E. coli cells containing the protein expression plasmid or the vector only were diluted 1:100 
in freshly prepared LB medium and incubated at 37°C with aeration (250 rpm) for 3 hours, 
followed by protein induction with L-arabinose (0.03%) for additional 2 hours. Cells were 
harvested and suspended in M9 minimal medium to O.D. = 8.0. The iron chelator 2,2’-dipydyl 
was then added to the cells, and incubated at 37°C for various times. Cells were then washed once 
with M9 minimal medium before being treated with NONOate at 37°C for 5 minutes. For the 
measurements of “chelatable iron pool” content, the cells were passed through the French press 
once, followed by centrifugation to remove cell debris. The amount of “chelatable intracellular 
iron” in cells was measured from the absorption peak at 520 nm of the iron-dipyridyl complex 
using an extinction coefficient of 5.2 mM-1cm-1 (53).  
Aconitase activity assay 
For the aconitase activity assay, an aliquot of freshly prepared cell extracts was transferred 
to a pre-incubated solution containing Tris (90 mM, pH 8.0) and D,L-isocitrate (20 mM) at 25°C 
as described in (25). The reaction was monitored at 240 nm using an extinction coefficient of 3.6 
mM-1cm-1 for aconitate in a Beckman DU640 UV-visible spectrophotometer equipped with a 
temperature controller. 
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EPR measurements 
The X-band EPR spectra were recorded using a Bruker model ESR-300 spectrometer 
equipped with an Oxford Instruments 910 continuous flow cryostat. Routine EPR conditions were: 
microwave frequency, 9.47 GHz; microwave power, 10.0 mW; modulation frequency, 100 kHz; 
modulation amplitude, 1.2 mT; temperature, 25 K; receive gain, 1 x 105. A freshly prepared 
glutathione-bound DNIC solution was used as a reference for quantification of protein-bound 
DNICs (12). 
 
3.3 Results 
 
Recombinant iron-sulfur proteins are modified to form protein-bound DNICs in E. coli cells 
under NO stress 
 
When wildtype E. coli cells were exposed to NO using the NO releasing reagent 
diethylamine NONOate, a unique EPR signal at g = 2.04 reflecting protein-bound DNICs (19-27) 
appeared, as reported previously (12). However, when recombinant iron-sulfur protein aconitase 
B (47) was expressed in the E. coli cells, the amount of protein-bound DNICs formed by the same 
NO exposure was significantly increased (Figure 3.1 A). A titration of the NONOate concentration 
revealed that the amount of protein-bound DNICs formed in E. coli cells with recombinant 
aconitase B was about twice as much as that of the E. coli cells without recombinant protein when 
the cells were exposed to 50 μM or more of NONOate (Figure 3.1 B). 
To further explore the correlation between iron-sulfur proteins and the NO-mediated 
formation of protein-bound DNICs, we expressed recombinant aconitase B in E. coli cells to 
various levels, followed by NO exposure. As shown in Figure 3.2, when the expression level of 
recombinant aconitase B was gradually increased (panel C), the amount of protein-bound DNICs 
formed in E. coli cells by NO was progressively increased (panel A). In control E. coli cells without 
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recombinant proteins (panel C), the total amount of protein-bound DNICs formed by NO remained 
essentially the same (panel B). Furthermore, recombinant aconitase B was purified from the NO-
exposed E. coli cells. The EPR measurements confirmed that aconitase B was modified forming 
aconitase B-bound DNIC in E. coli after NO exposure (Figure 3.2 D). Double integration analyses 
of the EPR signal at g = 2.04 indicated that purified aconitase B-bound DNIC accounted for 45-
70% of the extra protein-bound DNICs formed in the NO-exposed E. coli cells. 
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To determine whether other iron-sulfur proteins also contribute to the NO-mediated 
formation of protein-bound DNICs in vivo, we expressed recombinant dihydroxyacid dehydratase 
which contains a [4Fe-4S] cluster (48) in E. coli cells, and found similar correlation between the 
expression level of dihydroxyacid dehydratase and the amount of protein-bound DNICs formed in 
E. coli cells by NO (data not shown). To determine whether non-iron-sulfur proteins can also 
contribute to the NO-mediated formation of protein-bound DNICs in E. coli cells, we expressed 
both iron-sulfur proteins and non-iron-sulfur proteins under the same experimental conditions. 
Figure 3.3 shows that expression of recombinant iron-sulfur proteins dihydroxyacid dehydratase 
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(48) or the redox transcription factor SoxR (22) increased the amount of protein-bound DNICs in 
the E. coli cells by at least 100%. In contrast, expression of non-iron-sulfur proteins (the heat shock 
cognate protein HscA (49) and the single-stranded DNA binding protein SSB (50)) failed to 
increase the amount of protein-bound DNICs formed in E. coli cells, although both proteins were 
expressed to similar levels as dihydroxyacid dehydratase and SoxR (Figure 3.3 B). The EPR 
measurements of recombinant proteins purified from the NO-exposed E. coli cells further 
confirmed that while iron-sulfur proteins were modified forming protein-bound DNICs, the non-
iron-sulfur proteins did not form DNICs (data not shown). Thus, iron-sulfur proteins, but not the 
proteins without iron-sulfur clusters, are modified forming protein-bound DNICs in E. coli cells 
under NO stress. 
Deficiency of iron-sulfur cluster assembly largely eliminates the NO-mediated formation of 
protein-bound DNICs in E. coli cells 
 
In E. coli, iron-sulfur clusters are assembled by a group of proteins encoded by two gene 
clusters: iscRSUA-hscBA-fdx-iscX (ISC) (54) and sufABCDSE (SUF) (55). Among these iron-
sulfur cluster assembly proteins, IscA and SufA are paralogs with 47% sequence identity and 71% 
similarity. Both IscA and SufA have been proposed as iron donors (46) or alternative scaffold 
proteins (56) for the iron-sulfur cluster assembly. While deletion of IscA or SufA has only a mild 
effect in E. coli cells, deletion of both IscA and SufA results in deficiency of the [4Fe-4S] cluster 
assembly under aerobic conditions (45,46,57). Both the iscA-/sufA- double mutant and the wildtype 
cells were able to express recombinant aconitase B in the rich LB medium under aerobic growth 
conditions (Figure 3.4 A). However, unlike the wildtype cells, the iscA-/sufA- double mutant failed 
to assemble the [4Fe-4S] cluster in proteins under aerobic growth conditions (46) (Figure 3.4 B). 
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The wildtype and the iscA-/sufA- double mutant E. coli cells were then subjected to NO 
exposure. Figure 3.4 C shows that NO exposure of the iscA-/sufA- double mutant cells produced 
less than 5% of protein-bound DNICs observed in the wildtype cells. Further increase of NO 
concentration (up to 500 μM NONOate) failed to increase the amount of protein-bound DNICs 
formed in the iscA-/sufA- double mutant cells (data not shown). In parallel, the wildtype and the 
iscA-/sufA- double mutant cells containing recombinant aconitase B were also exposed to NO. 
Again, unlike in the wildtype E. coli cells, expression of recombinant aconitase B in the iscA-/sufA- 
double mutant cells did not significantly increase the amount of protein-bound DNICs (Figure 3.4 
C). Finally, recombinant aconitase B was purified from the NO-exposed wildtype and the iscA-
/sufA- double mutant E. coli cells. The EPR measurements confirmed that unlike that in the 
wildtype cells, recombinant aconitase B in the NO-exposed iscA-/sufA- double mutant cells was 
not modified by NO to form DNIC-bound aconitase. Similar results were obtained when 
recombinant dihydroxyacid dehydratase was expressed in the wildtype and the iscA-/sufA- double 
mutant E. coli cells (data not shown). Thus, deficiency of iron-sulfur cluster assembly largely 
eliminates the NO-mediated formation of protein-bound DNICs in E. coli cells. 
Depletion of the “chelatable iron pool” effectively removes iron-sulfur clusters from 
aconitase B and diminishes NO-mediated formation of protein-bound DNICs in E. coli cells 
  
 The “chelatable iron pool” has been defined as the loosely bound iron that can be depleted 
by membrane-permeable iron chelators (34). However, the exact chemical composition of the 
“chelatable iron pool” has not been defined (36,58). It would be pertinent to explore the possible 
link between iron-sulfur clusters in proteins and the “chelatable iron pool” in cells. 
To test this idea, the wildtype E. coli cells containing recombinant aconitase B were treated 
with a membrane-permeable iron chelator 2,2’-dipyridyl (59), followed by measurements of total 
aconitase activity in the cell extracts. The protein synthesis inhibitor chloramphenicol was added 
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to block new protein synthesis in the cells before addition of 2,2’-dipyridyl. Because aconitase B 
requires an intact [4Fe-4S] cluster for its activity (20), removal of iron-sulfur cluster from aconitase 
B would inactivate the enzyme. Figure 3.5 A shows that the total aconitase activity in the E. coli 
cells was gradually decreased as the concentration of 2,2’-dipyridyl in growth medium was 
increased and nearly abolished after the cells were incubated with 400 μM 2,2’-dipyridyl for 40 
minutes. 
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Recombinant aconitase B was also purified from the E. coli cells pre-treated with different 
concentrations of 2,2’-dipyridyl. Figure 3.5 B shows that the amount of iron-sulfur cluster in 
recombinant aconitase B (as indicated from the amplitude of the absorption peak at 413 nm) was 
gradually decreased as the concentration of 2,2’-dipyridyl in the growth medium was increased. 
Over 85% of iron-sulfur clusters in recombinant aconitase B expressed in E. coli cells was removed 
when E. coli cells were treated with 400 μM 2,2’-dipyridyl for 40 minutes. Similar results were 
obtained when the E. coli cells containing recombinant dihydroxyacid dehydratase (48) were 
treated with 2,2’-dipyridyl (data not shown). Thus, depletion of the “chelatable iron pool” 
effectively removes the iron-sulfur clusters from proteins in E. coli cells. 
The E. coli cells pre-treated with various concentrations of 2,2’-dipyridyl were then 
exposed to NO as described above. The amount of protein-bound DNICs formed in the E. coli 
cells after NO exposure was gradually decreased when the concentration of 2,2’-dipyridyl in 
growth medium was increased (data not shown), and closely correlated with the amount of iron-
sulfur clusters remained in recombinant aconitase B in the cells. 
We also followed the time course of the iron-sulfur cluster removal from recombinant 
aconitase B in E. coli cells in the presence of 2,2’-dipyridyl (400 μM). As shown in Figure 3.6 A 
and B, the amount of protein-bound DNICs in the E. coli cells was gradually decreased as the cells 
were incubated with 2,2’-dipyridyl (400 μM), and closely correlated with the amount of iron-sulfur 
clusters remained in recombinant aconitase B in the cells. Taking the results shown in Figure 3.6 
together, we concluded that depletion of the “chelatable iron pool” effectively removes iron-sulfur 
clusters from proteins and concomitantly diminishes the NO-mediated formation of protein-bound 
DNICs in E. coli cells. 
 
70 
 
 
Deficiency of iron-sulfur cluster assembly reduces the “chelatable iron pool” in E. coli cells  
Because depletion of the “chelatable iron pool” effectively removes iron-sulfur clusters 
from proteins, we reasoned that iron-sulfur clusters may be closely associated with the “chelatable 
iron pool” in E. coli cells. To test this hypothesis, we first compared the “chelatable iron pool” in 
the wildtype and the iscA-/sufA- double mutant E. coli cells. Figure 3.7 shows that the “chelatable 
iron pool” in the iscA-/sufA- double mutant cells was less than half of that found in the wildtype 
cells, indicating that deficiency of iron-sulfur cluster assembly significantly decreases the 
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“chelatable iron pool” in E. coli cells. We then compared the “chelatable iron pool” in the wildtype 
and the iscA-/sufA- double mutant E. coli cells containing recombinant aconitase B, and found that 
expression of recombinant aconitase B increased the “chelatable iron pool” in the wildtype E. coli 
cells but did not do so in the iscA-/sufA- double mutant cells. Similar results were obtained when 
dihydroxyacid dehydratase (48) was expressed in the wildtype and the iscA-/sufA- double mutant 
cells (data not shown). On the other hand, expression of recombinant non-iron-sulfur proteins 
HscA (49) and SSB (50) had no effect on the “chelatable iron pool” in the wildtype and the iscA-
/sufA- double mutant E. coli cells, suggesting that iron-sulfur clusters in proteins constitute at least 
part of the “chelatable iron pool” in E. coli cells. 
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3.4 Discussion 
Recent studies have shown that large molecular mass-bound DNICs are formed in cultured 
mammalian cells under NO stress (35,36). However, the exact chemical nature of large molecular 
mass-bound DNICs remains elusive (35,36). In this study, we demonstrate that iron-sulfur proteins 
are the major source of large molecular mass-bound DNICs formed in E. coli cells under NO stress. 
Expression of recombinant iron-sulfur proteins, but not proteins without iron-sulfur clusters, 
almost doubles the amount of protein-bound DNICs formed in E. coli cells under NO stress (Figure 
3.1). Purification of recombinant proteins from the NO-exposed E. coli cells further confirms that 
iron-sulfur proteins, but not the proteins without iron-sulfur clusters, are modified forming protein-
bound DNICs (Figures 3.2 and 3.3). Deletion of the iron-sulfur cluster assembly proteins IscA and 
SufA to prevent [4Fe-4S] cluster assembly in E. coli cells (45,46) largely eliminates the NO-
mediated formation of protein-bound DNICs. Furthermore, depletion of the “chelatable iron pool” 
in the wildtype E. coli cells effectively removes iron-sulfur clusters from proteins and 
concomitantly diminishes the NO-mediated formation of protein-bound DNICs, indicating that 
iron-sulfur clusters in proteins are in dynamic equilibrium with the “chelatable iron pool” in cells.  
Previous studies indicated that proteins without iron-sulfur clusters such as bovine serum 
albumin could also form DNICs with excess ferrous iron and NO in vitro (60,61). However, we 
were unable to observe the DNICs formation in the proteins without iron-sulfur clusters in E. coli 
cells under NO stress (Figure 3.3). One possible explanation is that excess iron and NO used in 
the in vitro studies may form transient DNICs that are subsequently transferred to proteins via 
thiol-ligand exchange (60,61). It seems that exceedingly low concentration of intracellular “free” 
iron (62,63) may prevent formation of DNICs in the proteins without iron-sulfur clusters in E. coli 
cells under NO stress. In contrast, iron-sulfur clusters in proteins are readily modified by NO 
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forming protein-bound DNICs in vitro (19-27) and in vivo (8,12), and direct modification of iron-
sulfur clusters in proteins by NO has been attributed to the NO-mediated bacteriostasis of E. coli 
under aerobic and anaerobic growth conditions (8,12) and NO-dependent killing of Burkholderia 
mallei (13). Thus, at pathological NO concentrations (μM) (37,38), iron-sulfur proteins, but not 
“free” iron, constitute the major source of protein-bound DNICs formed in E. coli cells. 
The E. coli mutant with deficiency in iron-sulfur cluster assembly provides a unique 
opportunity to further illustrate the role of iron-sulfur clusters in the NO-mediated formation of 
protein-bound DNICs in vivo. Previous studies showed that deletion of both IscA and SufA results 
in deficiency of the [4Fe-4S] cluster assembly in E. coli cells under aerobic growth conditions 
(45,46). Here we find that deficiency of the [4Fe-4S] cluster assembly due to deletion of IscA and 
SufA largely eliminates the NO-mediated formation of protein-bound DNICs in E. coli cells 
(Figure 3.4), demonstrating that iron-sulfur clusters are mainly responsible for the NO-mediated 
formation of protein-bound DNICs in E. coli cells.  
The cellular “chelatable iron pool” has been described as the iron content that can be 
depleted with membrane-permeable iron chelators (34), and has been proposed as the major iron 
source for formation of large molecular mass-bound DNS under NO stress (34-36). However, the 
exact chemical composition of the “chelatable iron pool” has not been defined (35,36,58). It is also 
possible that bacteria and mammalian cells may have a distinct “labile iron pool”. In this study, 
we find that depletion of the “chelatable iron pool” with the strong iron chelator 2,2’-dipyridyl 
effectively removes iron-sulfur clusters from recombinant aconitase B (Figure 3.5) or 
dihydroxyacid dehydratase in E. coli cells. We propose that iron-sulfur clusters are at least part of 
the “chelatable iron pool” in bacterial cells. The equilibrium between the “chelatable iron pool” 
and iron-sulfur clusters in proteins was previously implicated in regulation of the iron regulatory 
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protein IRP-1 / cytosolic aconitase in mammalian cells (62,63). IRP-1 is an iron-sulfur protein 
with cytosolic aconitase activity. When the “chelatable iron pool” is depleted, the [4Fe-4S] cluster 
in IRP-1 is removed, resulting in apo-IRP-1 that binds the iron responsive elements (IREs) of target 
mRNAs to promote intracellular iron content (55,56). When intracellular iron content is 
replenished, the [4Fe-4S] cluster is re-assembled in apo-IRP-1 to prevent accumulation of excess 
intracellular iron. Similar equilibrium between the “chelatable iron pool” and iron-sulfur clusters 
in proteins have been reported for the iron-sulfur cluster assembly regulator IscR (64,65), the 
anaerobic growth factor FNR (66), and the NO sensor NsrR (14), among other iron-sulfur proteins 
in bacteria (10,67). Our results presented in this study are entirely consistent with the hypothesis 
that the “chelatable iron pool” is in dynamic equilibrium with iron-sulfur clusters in proteins 
(Figure 3.6). Although the molecular details underlying iron exchange between the “chelatable 
iron pool” and iron-sulfur clusters in proteins could only be speculated at present, decrease of 
“chelatable iron content” in the E. coli mutant cells with deficiency of iron-sulfur cluster assembly 
and an increase of “chelatable iron content” in the wildtype E. coli cells containing recombinant 
iron-sulfur protein aconitase B (Figure 3.7) clearly suggest that iron-sulfur clusters in proteins at 
least contribute to part of the “chelatable iron pool” in E. coli cells. 
Throughout evolution, iron-sulfur proteins have become integral parts of diverse 
physiological processes (15,16). Over 500 unique iron-sulfur proteins have been identified in 
various organisms (15). Modification of iron-sulfur proteins by NO is expected to have a broad 
impact on cellular functions. If cells are to survive, the NO-modified iron-sulfur proteins must be 
efficiently repaired. Although the biomimetic model studies suggest that DNIC may be directly 
converted back to iron-sulfur clusters (68), the cellular repair mechanism appears to be more 
complex. It has been shown that the genes encoding the iron-sulfur cluster assembly machinery 
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are highly induced in E. coli cells under NO stress (6-9), suggesting that these proteins could be 
directly involved in repair of the NO-modified iron-sulfur clusters. Recently, we have shown that 
L-cysteine and oxygen are two key components for decomposition of protein-bound DNICs in 
vitro and in vivo (27). However, re-assembly of new iron-sulfur clusters must occur in order to 
fully restore the function of NO-modified iron-sulfur proteins. Understanding the dynamic 
exchange between intracellular iron and iron-sulfur clusters in proteins will be crucial to elucidate 
cellular repair mechanism for the NO-modified iron-sulfur proteins. 
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CHAPTER 4 
THE N-TERMINAL DOMAIN OF HUMAN DNA HELICASE RTEL1 CONTAINS A 
REDOX ACTIVE IRON-SULFUR CLUSTER 3 
 
4.1 Introduction 
 In vertebrates, telomeres are the protective structures at the end of chromosomes, and are 
composed of both repetitive TTAGGG sequences and associated proteins that form a core structure 
known as the Shelterin complex (1,2). Telomeres become shorter with each round of DNA 
replication, and are compensated for by telomerase (3). In addition to telomerase, the telomere 
length is regulated by other genetic (4) and epigenetic (5) factors. Among them, Regulator of 
telomere length 1 (Rtel1) has an essential role in maintaining proper length of telomeres (4,6). 
Deletion of Rtel1 in mice is embryonic lethal with increased incidence of chromosomal 
abnormalities and telomere loss (4). In humans, Rtel1 is highly expressed in several types of 
tumor tissues (7), and specific mutations in Rtel1 have been attributed to Dyskeratosis congenita 
and Hoyeraal-Hreidarsson syndrome (8,9). 
 Human Rtel1 is a superfamily II DNA helicase (10), and is homologous to other human 
DNA helicases XPD (Xeroderma pigmentosum factor D) (11), FancJ (Fanconi’s anaemia 
complementation group J) / BACH1 (for BRCA1-associated C-terminal helicase) (12,13), and 
ChlR1 (a protein required for normal mitotic progression) (14). However, unlike other DNA 
helicases, Rtel1 preferentially disrupts the D-loop within the T-loop structure formed at the end of 
telomeres (15) and may act as an anti-recombinase to prevent the formation of D-loops (6,16). In 
the absence of Rtel1, the T-loop structure could be erroneously resolved as a substrate for 
                                                 
3 This chapter previously appeared as: Landry, A. P., and Ding, H. (2014) The N-terminal domain 
of human DNA helicase Rtel1 contains a redox active iron-sulfur cluster. BioMed research 
international 2014, 285791. Modified and reprinted with permission of Hindawi Publishing 
Corporation. 
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homologous recombination (16), leading to telomere deficiency. On the other hand, excessive 
activity of Rtel1 would be detrimental as increased Rtel1 helicase activity would disengage the 
T-loop structure, leading to telomere de-protection and genomic instability (16). Thus, the 
helicase activity of Rtel1 must be tightly regulated to maintain proper length of telomeres in 
chromosomes (6). 
 The sequence alignment analyses revealed that the N-terminal domain of human Rtel1 
contains a conserved region for hosting a putative iron-sulfur cluster via four cysteine residues 
(Figure 4.1) (17). It has previously been reported that the DNA helicase Rad3 from yeast (18), and 
XPD homologs from archaea (19-22), DNA-damage-inducible DNA helicase DinG from 
Escherichia coli (23), and AddAB-type helicase-nuclease from Bacillus subtilis (24) contain a 
[4Fe-4S] cluster essential for the helicase activity. However, the existence of the iron-sulfur 
cluster in any human DNA helicases has not been experimentally demonstrated. Here, we report 
that expression of the N-terminal domain (residues 1-312) of human Rtel1 (RtelN) in E. coli cells 
produces a protein that contains a redox active iron-sulfur cluster with redox midpoint potential 
(Em) of -248 ± 10 mV (pH 8.0). Purified RtelN retains a weak binding activity for the single-
stranded (ss) and double-stranded (ds) DNA, and disruption of the iron-sulfur cluster by hydrogen 
peroxide or nitric oxide does not affect the DNA binding activity of RtelN, suggesting that iron-
sulfur cluster in the N-terminal domain may not be directly involved in DNA interaction in Rtel1. 
 
4.2 Materials and Methods 
Protein preparation 
 The DNA fragment encoding the N-terminal domain (RtelN, residues 1-312) of human 
Regulator of Telomere Length 1 (Rtel1) was synthesized for expression in E. coli cells 
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(Genescript). The gene was subcloned into an expression plasmid pET28b+ which was introduced 
into E. coli BL21(DE3) cells. The E. coli cells hosting the expression plasmid were grown in LB 
medium to an O.D. at 600 nm of ~0.6 before isopropyl β-D-1-thiogalactopyranoside (200 μM) was 
added to induce the protein expression for three hours. The cells were harvested and passed through 
French press once. Recombinant RtelN in pellets was solubilized by adding urea (6 M), and the 
protein was purified using a nickel-agarose column attached to a FPLC system (GE Biosciences), 
followed by passing through a HiTrap desalting column. The molecular weight of RtelN was 
confirmed by MALDI mass spectrometry (Chemistry Department, LSU). The concentration of 
purified RtelN was measured from the absorption peak at 280 nm using an extinction coefficient 
of 25.5 mM-1cm-1. The total iron content in purified RtelN sample was determined using an iron 
indicator FerroZine (25). The total acid-labile sulfide content was determined according to the 
Siegel’s method (26). The single-stranded DNA binding protein SSB (27) was prepared as 
described previously (28). 
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The DNA binding activity assay of RtelN 
 The DNA binding activity assay was carried out using a fluorescence labeled 40mer (5’-
F*-AATTGCGATCTAGCTCGCCAGUAGCGACCTTATCTGATGA-3’). For single-stranded 
(ss) DNA binding assay, the 40mer (0.5 μM) was incubated with increasing concentrations of 
protein in buffer containing Tris (20 mM, pH 8.0), NaCl (50 mM), β-mercaptoethanol (1mM), 
MgCl2 (1mM), and bovine serum albumin (0.5 mg/mL). For the double-strand (ds) DNA binding 
assay, the fluorescence-labeled 40mer was annealed to a complementary ssDNA in an annealing 
buffer containing Tris (50 mM, pH 8.0), NaCl (50 mM), and MgCl2 (10 mM). Prepared dsDNA 
labeled with fluorescence was incubated with increasing concentrations of protein in buffer as 
described above. After incubation at room temperature for 15 minutes, samples were loaded on to 
a 0.6% agarose gel in TAE buffer. The agarose gel was run at 10 volts/cm for 30 minutes at room 
temperature and photographed in a KODAK Gel Logic 200 Imaging System. 
Redox titration of the RtelN iron-sulfur cluster 
 A specially-designed cuvette was used for redox titration experiments as described by 
Dutton (29). Purified RtelN (20 μM) dissolved in buffer containing Tris (50 mM, pH 8.0) and 
NaCl (500 mM) was incubated with a redox mediator safranin O (1 μM) in a sealed cuvette and 
equilibrated with pure argon gas for 45 minutes at room temperature. The redox potential was 
adjusted by adding a small amount of freshly prepared sodium dithionite using a gas-tight 10-µl 
Hamilton micro-syringe (Hamilton Inc.). The redox potential was monitored with a redox 
microelectrode (Microelectrodes Inc.) which was calibrated using a standard ZoBell solution (Eh 
= +238 mV) containing potassium ferricyanide (5 mM) and potassium ferrocyanide (5 mM) in 
buffer containing Tris (20 mM, pH 8.0) and NaCl (500 mM). The redox titration data were fitted 
to the Nernst Equation with n = 1 using KaleidaGraph (Synergy Software). 
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Hydrogen peroxide and nitric oxide treatments of RtelN 
 For hydrogen peroxide (H2O2) treatments, purified RtelN was incubated with different 
concentrations of H2O2 at room temperature for 30 minutes, followed by re-purification of the 
protein from the incubation solutions. For nitric oxide (NO) treatments, purified RtelN dissolved 
in a sealed vial was purged with pure argon gas for 15 minutes, followed by incubation with the 
NO-releasing reagent diethylamine NONOate (Cayman Chemicals co.) at 37oC for 10 minutes. 
RtelN was re-purified after the NO treatment. Modification of the iron-sulfur cluster in RtelN by 
H2O2 or NO was quantified by UV-visible absorption spectrophotometry. 
Circular dichroism (CD) and electron paramagnetic resonance (EPR) measurements 
 Circular dichroism (CD) spectra were recorded on a Jasco J-815 CD spectrometer 
(AgCenter Biotechnology Laboratories, LSU) at room temperature. The composition of secondary 
structures was obtained using the CDNN program (30). The electron paramagnetic resonance 
(EPR) spectra were recorded at X-band on a Bruker ESR-300 spectrometer equipped with an 
Oxford Instruments 910 continuous flow cryostat. EPR conditions were as follows: microwave 
frequency, 9.45 GHz; microwave power, 10 mW; modulation frequency, 100 kHz; modulation 
amplitude, 2 mT; sample temperature, 10 K; receive gain, 1 x 105. 
 
4.3 Results 
The N-terminal domain of human Rtel1 hosts an iron-sulfur cluster 
 When the N-terminal domain of human Rtel1 (RtelN) was expressed in E. coli cells, the 
cell pellets were dark red in color (Figure 4.2 A insert). Recombinant RtelN was then purified from 
the E. coli cells as described in Materials and Methods. The UV-visible absorption measurements 
showed that purified RtelN had an absorption peak at 415 nm (Figure 4.2 A), similar to that of the 
S. acidocaldarius XPD [4Fe-4S] cluster (22) and the E. coli DinG [4Fe-4S] cluster (23). Purified 
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RtelN was further subjected to circular dichroism (CD) measurements. As shown in Figure 4.2 B, 
purified RtelN adopted an ordered structure with about 25% alpha-helix, 32% beta-sheet, 20% 
beta turns, and 22% random coil. The iron and sulfide content analyses revealed that purified RtelN 
contained 0.83 ± 0.13 iron and 0.75 ± 0.16 acid-labile sulfide per protein. 
 The low iron and sulfide content in purified RtelN could be due to the protein purification 
process carried out under denaturing conditions. To reconstitute iron-sulfur clusters in RtelN, re-
natured protein was reconstituted with excess iron and sulfide as described previously (23). After 
reconstitution, the iron and sulfide contents in RtelN were increased to 3.5 ± 0.3 iron and 3.2 ± 0.5 
sulfide per RtelN, respectively, indicating that each RtelN monomer may bind a [4Fe-4S] cluster. 
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The iron-sulfur cluster in RtelN is redox active 
 When freshly prepared sodium dithionite was added to the solution containing RtelN, the 
absorption peak at 415 nm of the RtelN iron-sulfur cluster was completely eliminated (Figure 4.3 
A). The absorption peak at 415 nm was restored when the reduced RtelN iron-sulfur cluster was 
re-oxidized by oxygen (data not shown), suggesting that the RtelN iron-sulfur cluster can be 
reversibly reduced. This notion was further confirmed by EPR measurements: while purified RtelN 
was EPR silent, addition of sodium dithionite to purified RtelN produced an EPR spectrum with 
gx = 1.918, gy = 1.994 and gz = 2.050 (Figure 4.3 B), a spectrum similar that of the reduced E. coli 
DNA helicase DinG [4Fe-4S] cluster (23). 
 Redox titration experiments were then carried out to determine the redox midpoint 
potential (Em) of the RtelN iron-sulfur cluster. The amplitude of the absorption peak at 415 nm 
of RtelN were plotted as a function of redox potentials in the solution (Figure 4.3 C). The data 
from three sets of experiments were fitted to a Nernst equation (n = 1) with an Em of -248 ± 10 mV 
at pH 8.0, which is about 140 mV higher than that of the E. coli DinG [4Fe-4S] cluster (23). 
Purified RtelN has a weak DNA binding activity 
 The N-terminal domain of the archaeal DNA helicase XPD comprises part of the catalytic 
center (20). To test whether the N-terminal domain of Rtel1 also contributes to the catalytic site, 
we examined the DNA binding activity of purified RtelN. As shown in Figure 4.4 A, purified 
RtelN formed a protein-DNA complex with the single-stranded (ss) DNA. FhuF, an iron-sulfur 
protein with similar in molecular weight to RtelN but with no known DNA binding activity (31), 
failed to bind any ssDNA, indicating that the ssDNA binding in RtelN is specific. Nevertheless, 
compared with the single-stranded DNA binding protein SSB (27), the binding affinity of RtelN 
for ssDNA was at least 10-fold weaker. In parallel, we also determined the double-stranded (ds)  
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DNA binding activity of RtelN under the same experimental conditions. Figure 4.4 B shows that 
RtelN could also bind dsDNA with the similar binding affinity as for ssDNA. In contrast, both 
FhuF and SSB did not bind any dsDNA as expected. Thus, purified RtelN has a binding activity 
for both ssDNA and dsDNA in vitro. 
 
The iron-sulfur cluster is not required for the DNA binding activity of RtelN 
 Ironically, iron-sulfur clusters in proteins are often sensitive to reactive oxygen species 
(32) and nitrogen species (33,34). To test if the iron-sulfur clusters in RtelN can be modified by 
reactive oxygen species, we incubated RtelN with hydrogen peroxide at room temperature. Figure 
4.5 A shows that addition of increasing amounts of hydrogen peroxide removed the absorption 
peak at 415 nm of purified RtelN, indicating that the iron-sulfur cluster in RtelN are disrupted by 
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hydrogen peroxide. Purified RtelN was also incubated with the nitric oxide-releasing reagent 
diethylamine NONOate in solution. Again, the absorption peak at 415 nm of the RtelN iron-sulfur 
cluster was largely abolished as the concentration of nitric oxide was increased (Figure 4.5 B). 
Thus, the iron-sulfur cluster in RtelN is sensitive to both hydrogen peroxide and nitric oxide. 
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 We then sought to examine the DNA binding activity of RtelN after the protein was treated 
with hydrogen peroxide and nitric oxide. Figure 4.5 C shows that the DNA binding activity of 
RtelN remained nearly unchanged when the iron-sulfur cluster was modified by hydrogen peroxide 
or nitric oxide, suggesting that the iron-sulfur cluster is not required for the DNA binding activity 
of RtelN. 
 
4.4 Discussion 
 Recent studies have identified a new set of iron-sulfur cluster-containing enzymes that are 
involved in DNA processing in bacteria and eukaryotic cells (17). Among these enzymes are a 
group of DNA helicases that require an intact iron-sulfur cluster for the DNA helicase activity 
(11,35). For example, it has been shown that the DNA helicase Rad3 from yeast and XPD 
homologs from archaea contain a [4Fe-4S] cluster essential for the enzyme activity (19-22). In 
human XPD, mutations in the N-terminal domain that hosts a putative iron-sulfur cluster have been 
associated with several genetic diseases including Xeroderma pigmentosum (20). Interestingly, in 
addition to XPD, humans have at least three other DNA helicases: FancJ (Fanconi’s anaemia 
complementation group J) / BACH1 (for BRCA1-associated C-terminal helicase) (12,13), ChlR1 
(a protein required for normal mitotic progression) (14) and Rtel1 of telomere length regulation 
(4,6) that contain a putative iron-sulfur cluster binding site in the N-terminal domain (Figure 4.1). 
However, the existence of the [4Fe-4S] clusters in any of these human DNA helicases has not been 
experimentally demonstrated. Here we find that the N-terminal domain of human Rtel1 (RtelN) 
expressed in E. coli cells contains a redox active [4Fe-4S] cluster, and that the iron-sulfur cluster 
in purified RtelN is highly sensitive to hydrogen peroxide and nitric oxide. The results suggest that 
human Rtel1, like XPD from archaea (19-22), likely contains a [4Fe-4S] cluster. 
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 Despite the findings of the iron-sulfur clusters in these DNA helicases, specific function of 
the [4Fe-4S] clusters in the DNA helicases remains largely elusive (17). In previous studies, we 
reported that oxidation of the reduced iron-sulfur cluster in E. coli DNA helicase DinG reversibly 
switches on the enzyme activity, and proposed that iron-sulfur cluster may regulate the helicase 
activity in response to redox signals (23). Here, we have tested the idea further in the human DNA 
helicase Rtel1. While attempts to purify a full-length human Rtel1 from E. coli cells were not 
successful, we were able to prepare the soluble N-terminal domain (residues 1 – 312) of human 
Rtel1 (RtelN). The results demonstrated that RtelN contains a redox active iron-sulfur cluster with 
a redox midpoint potential of -248 ± 10 mV at pH 8.0 (Figure 4.3). The redox potential in cytosol 
and nucleus of mammalian cells has been reported to be around -325 mV (pH 7.0) (36). However, 
when cells are under oxidative stress or during apoptosis and differentiation, the intracellular redox 
potential could increase to as high as +200 mV (37). Assuming the redox midpoint potential of the 
iron-sulfur cluster in Rtel1 is similar to that in RtelN, we would expect that the iron-sulfur cluster 
in Rtel1 is in reduced state in cells under normal physiological conditions. Under oxidative stress 
or during apoptosis and differentiation (37), the iron-sulfur cluster in Rtel1 would be fully 
oxidized. We envision that oxidation of the reduced iron-sulfur cluster in Rtel1, like that in the E. 
coli DinG (23), may change the DNA helicase activity of the protein in response to redox signals. 
Thus, fluctuation of intracellular redox potential may result in the change of Rtel1 DNA helicase 
activity by changing the redox state of the iron-sulfur cluster. While the iron-sulfur cluster appears 
to be dispensable for the DNA binding activity of purified RtelN (Figure 4.5), the iron-sulfur 
cluster could have an important role in other steps of the reaction catalyzed by Rtel1. 
 The telomere length of chromosomes has been linked to intracellular oxidative stress in 
human cells (38). The finding that the RtelN iron-sulfur cluster is sensitive to hydrogen peroxide 
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and nitric oxide (Figure 4.5) may provide a rational explanation for the association between the 
telomere length of chromosomes and oxidative stress in cells. Since the iron-sulfur cluster is 
essential for the DNA helicase activity of XPD from yeast and archaea (19-22), disruption of iron-
sulfur clusters in protein would likely change the helicase activity of Rtel1 in human cells. If the 
iron-sulfur cluster in Rtel1 is as sensitive to hydrogen peroxide or nitric oxide as that in RtelN, the 
DNA helicase activity of Rtel1 could be modulated by intracellular reactive oxygen / nitrogen 
species. Therefore, modification of iron-sulfur cluster in Rtel1 by these species could at least in 
part contribute to telomere length of chromosomes in cells (38). Evidently, additional 
experiments are required to illustrate the regulatory role of the iron-sulfur cluster in the human 
Rtel1 and other DNA helicases. 
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CHAPTER 5 
REDOX CONTROL OF HUMAN MITOCHONDRIAL PROTEIN MITONEET [2FE-2S] 
CLUSTERS BY BIOLOGICAL THIOLS AND HYDROGEN PEROXIDE 4 
 
5.1 Introduction 
 Human mitochondrial protein mitoNEET is a novel target of type II diabetes drug class of 
thiazolidinediones, such as pioglitazone (1). Genetic studies have shown that deletion of 
mitoNEET in mice results in a reduced oxidative phosphorylation capacity in mitochondria (2). 
While increased expression of mitoNEET in adipocytes in mice enhances lipid uptake and storage 
and inhibits mitochondrial iron transport into the matrix, depletion of mitoNEET in adipocytes 
leads to reduced weight gain in mice (3), suggesting that mitoNEET may regulate energy 
metabolism in mitochondria (1). Recent studies further indicated that mitoNEET may have a 
central role in neurodegenerative diseases (4,5) and breast cancer proliferation (6) by maintaining 
mitochondrial homeostasis in cells.  
 MitoNEET localizes on mitochondrial outer membranes (2) via the N-terminal 
transmembrane α-helix (residues 14 to 32) (1). Expression of the soluble C-terminal domain 
(residues 33-108) of mitoNEET in Escherichia coli cells produced a protein that contains a [2Fe-
2S] cluster (7). Crystallographic studies revealed that mitoNEET exists as a homodimer, with each 
monomer hosting a [2Fe-2S] cluster via an unusual ligand arrangement of three cysteine (Cys-72, 
Cys-74 and Cys-83) and one histidine (His-87) residues (8-10). The [2Fe-2S] clusters in 
mitoNEET are redox active with the redox midpoint potential at pH 7.0 (Em7) of ~0 mV (11,12). 
Substitution of the unique His-87 with cysteine in mitoNEET shifts the Em7 value of the [2Fe-2S] 
                                                 
4 This chapter previously appeared as: Landry, A. P., and Ding, H. (2014) Redox control of human 
mitochondrial outer membrane protein MitoNEET [2Fe-2S] clusters by biological thiols and 
hydrogen peroxide. The Journal of biological chemistry 289, 4307-4315. Modified and reprinted 
with permission of the American Society of Biochemistry and Molecular Biology. 
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clusters from ~0 mV to -320 mV (11) and increases the stability of the cluster in the protein (13). 
The redox property and stability of the [2Fe-2S] clusters in mitoNEET are also modulated by type 
II diabetes drug pioglitazone (11), excess zinc (14), resveratrol-3-sulfate (15), NADPH (16), the 
inter-domain interactions (17,18), and the hydrogen bond network in the protein (19), suggesting 
that mitoNEET may act as a sensor of multiple signals to regulate mitochondrial functions (19). 
Interestingly, purified mitoNEET can also transfer the [2Fe-2S] clusters to apo-protein with 50% 
completion time of about 120 minutes at room temperature (20,21). As mitochondria are the 
primary sites for iron-sulfur cluster biogenesis (22), it is appealing to consider that mitoNEET may 
participate in the iron-sulfur cluster biogenesis process in human cells (20,21). Nevertheless, the 
iron-sulfur cluster transfer occurs only when the [2Fe-2S] clusters in mitoNEET are oxidized (20), 
and the cluster transfer process is inhibited by NADPH (21), suggesting that the mitoNEET-
mediated iron-sulfur cluster transfer could be regulated by the redox state of the [2Fe-2S] clusters 
and by intracellular NADPH. 
 Since the cytosolic redox potential in eukaryotic cells is estimated to be around -325 mV 
(pH 7.0) (23), it is expected that the mitoNEET [2Fe-2S] clusters (Em7 = ~0 mV) (11,12) would be 
in reduced state in cells under physiological conditions. Nevertheless, the redox state of the 
mitoNEET [2Fe-2S] clusters in cells has not been demonstrated, and specific cellular components 
that may reduce the mitoNEET [2Fe-2S] clusters have not been identified. Here we report that 
human mitoNEET [2Fe-2S] clusters are in the fully reduced state when expressed in E. coli cells 
under normal growth conditions, and that purified mitoNEET [2Fe-2S] clusters can be partially 
reduced by monothiols such as reduced glutathione, L-cysteine and N-acetyl-L-cysteine, and fully 
reduced by dithiothreitol and E. coli thioredoxin reduced by thioredoxin reductase and NADPH. 
Importantly, the reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen 
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peroxide without disruption of the clusters, indicating that the redox state of the mitoNEET [2Fe-
2S] clusters can be modulated by biological thiols and oxidative signals. Furthermore, we find that 
type II diabetes drug pioglitazone can effectively inhibit the thiol-mediated reduction of the 
mitoNEET [2Fe-2S] clusters in vitro, suggesting that pioglitazone may modulate the function of 
mitoNEET by blocking the thiol-mediated reduction of the [2Fe-2S] clusters in the protein. 
 
5.2 Materials and Methods  
Protein purification 
 The gene encoding human mitoNEET33–108 (containing amino acid residues 33-108) was 
previously cloned from the human cDNA library as described in (14). The mitoNEET mutant in 
which histidine 87 was substituted with cysteine (H87C) was constructed using the QuikChange 
site-directed mutagenesis kit (Stratagene). The constructed mutation was confirmed by direct 
sequencing (Operon). Human mitoNEET and the mitoNEET mutant proteins were prepared 
following the procedures described previously (14). E. coli thioredoxin (TrxA) and thioredoxin 
reductase (TrxB) were produced from E. coli cells using the expression vectors pDL59 (24) and 
pTrR301 (25), respectively, and purified as described in (26). Both E. coli thioredoxin and 
thioredoxin reductase were purified in the native form. The purity of purified proteins was greater 
than 95% as judged by electrophoresis analysis on a 15% polyacrylamide gel containing SDS 
followed by staining with Coomassie Blue. The protein concentration of purified mitoNEET or 
the mitoNEET mutant H87C was measured at 280 nm using an extinction coefficient of 8.6 mM-
1cm-1. The protein concentration of thioredoxin and thioredoxin reductase was determined at 280 
nm using extinction coefficient of 14.2, and 17.7 mM-1 cm-1, respectively. A Beckman DU640 
UV-visible spectrophotometer equipped with a temperature control was used for measuring 
absorption spectra. 
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EPR measurements 
 For the whole cell EPR (electron paramagnetic resonance) measurements, E. coli cells were 
grown for two hours before the recombinant protein expression was induced. After two hours of 
protein expression, cells were harvested and washed once with phosphate buffer (pH 7.5) and re-
suspended in phosphate buffer or fresh LB medium. An aliquot (350 μL) of the E. coli cells was 
then transferred to an EPR tube and frozen immediately in liquid nitrogen. For the reduced 
samples, freshly prepared sodium dithionite was added to the E. coli cells before the EPR samples 
were prepared. For the protein sample preparation, purified mitoNEET [2Fe-2S] clusters dissolved 
in buffer containing 20 mM Tris (pH 8.0) and 500 mM NaCl were purged with pure argon gas in 
sealed vials for 15 minutes before the reductant was added under anaerobic conditions. After 
incubation at 37°C for 20 minutes, the samples were transferred to EPR tubes and frozen 
immediately in liquid nitrogen. The X-band EPR spectra were recorded using a Bruker model 
ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow cryostat. 
Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power, 10.0 mW; 
modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 20 K; receive gain, 
2 x 105.  
Chemicals 
 Pioglitazone, L-cysteine, N-acetyl-L-cysteine, reduced glutathione, and other chemicals 
were purchased from Sigma. Isopropyl β-D-1-thiogalactopyranoside (IPTG), NADPH, 
kanamycin, ampicillin, and dithiothreitol were from Research Products International. Pioglitazone 
was dissolved in DMSO as a stock solution containing 25 mM pioglitazone. An equal amount of 
DMSO was added to the samples as a control. 
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5.3 Results 
Human mitoNEET [2Fe-2S] clusters expressed in E. coli cells are fully reduced 
 Purified human mitoNEET [2Fe-2S] clusters are in oxidized state and have no 
paramagnetic resonance (EPR) signals (Figure 5.1 A). When purified mitoNEET [2Fe-2S] clusters 
were reduced with sodium dithionite, a strong reductant with Em7 = -660 mV (27), an rhombic 
EPR spectrum with gx = 1.895, gy = 1.937, and gz = 2.005 appeared (Figure 5.1 A), as reported 
previously (7,19,28,29). In parallel, we also prepared the mitoNEET mutant H87C in which the 
unique ligand His-87 of the [2Fe-2S] cluster is replaced with cysteine. While purified mitoNEET 
H87C had no EPR signal, addition of sodium dithionite produced a new rhombic EPR spectrum 
of the [2Fe-2S] cluster with gx = 1.896, gy = 1.970, and gz = 1.992, which is distinct from that of 
the wildtype mitoNEET (Figure 5.1 A). 
 EPR measurement provides an efficient and non-intrusive approach to determine the redox 
state of iron-sulfur clusters in proteins dissolved in solutions or within whole cells (30,31). Here, 
we took advantage of EPR spectroscopy to explore the redox state of the mitoNEET [2Fe-2S] 
clusters expressed in E. coli cells. Figure 5.1 B shows that the E. coli cells without any recombinant 
proteins have very little or no EPR signals, due to low concentrations of endogenous iron-sulfur 
proteins in cells (30,31). Under the same experimental conditions, the E. coli cells expressing 
human mitoNEET show a rhombic EPR signal at g = 1.94 which is identical to that of the reduced 
mitoNEET [2Fe-2S] clusters (Figure 5.1 A). In contrast, the E. coli cells expressing the mitoNEET 
mutant H87C did not have any EPR signals (Figure 5.1 B), although both mitoNEET and the 
mitoNEET mutant H87C are expressed similarly in E. coli cells based on the SDS-PAGE gel 
analysis (data not shown). This is likely because the mutation of His-87 to cysteine shifts the Em7 
value of the mitoNEET [2Fe-2S] clusters from ~0 mV to -320 mV (11). Since the cytosolic redox 
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potential of E. coli cells is about -260 mV (32), the mitoNEET mutant H87C [2Fe-2S] clusters 
would be mostly in oxidized (and thus EPR silent) state in E. coli cells. 
 
 To further examine the redox state of the [2Fe-2S] clusters in the wildtype mitoNEET and 
the mitoNEET mutant H87C expressed in E. coli cells, excess sodium dithionite was added to the 
cells to reduce all iron-sulfur proteins. Figure 5.1 C shows that addition of sodium dithionite to the 
E. coli cells without recombinant proteins does not produce any new EPR signals. On the other 
hand, addition of sodium dithionite to the E. coli cells expressing the mitoNEET mutant H87C 
generated an EPR signal at g = 1.97 which is the same as that of the reduced mitoNEET mutant 
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H87C [2Fe-2S] clusters (Figure 5.1 A). Thus, the oxidized [2Fe-2S] clusters of the mitoNEET 
mutant H87C in E. coli cells can be reduced by sodium dithionite. In contrast, the EPR signal at g 
= 1.94 of the E. coli cells expressing the wildtype mitoNEET was not changed by addition of 
sodium dithionite, suggesting that the wildtype mitoNEET [2Fe-2S] clusters are fully reduced in 
E. coli cells even before addition of sodium dithionite. Since the cytosolic redox potential in 
eukaryotic cells (-325 mV (23)) is about 65 mV lower than that in E. coli cells (-260 mV (32)), we 
postulate that the mitoNEET [2Fe-2S] clusters are most likely in reduced state in human cells 
under physiological conditions. 
Human mitoNEET [2Fe-2S] clusters can be reduced by biological thiols 
 Although it has been shown that the mitoNEET [2Fe-2S] clusters are redox active (11,12), 
specific biological molecules that can reduce or oxidize the mitoNEET [2Fe-2S] clusters are 
unknown. Since the mitoNEET [2Fe-2S] clusters are fully reduced in E. coli cells, we reason that 
the mitoNEET [2Fe-2S] clusters may be reduced by cellular reducing components that are 
common in both human and E. coli cells. However, NADPH is not one of them, as NADPH fails 
to reduce the mitoNEET [2Fe-2S] clusters in vitro (21). Among other cellular reducing 
components, biological thiols are abundant. More importantly, biological thiols are able to form 
intermediate thiol free radicals (33,34) which can potentially provide electrons for the single-
electron reduction of the oxidized [2Fe-2S] clusters in mitoNEET. 
 To test this idea, purified mitoNEET was incubated with thiols under anaerobic conditions. 
After incubation, the samples were subjected to the EPR and UV-visible absorption measurements. 
The reduced mitoNEET [2Fe-2S] clusters were observed from the EPR signal at g = 1.94 and the 
UV-visible absorption peaks at 420 nm and 550 nm. As shown in Figure 5.2, all biological thiols 
tested (reduced glutathione, L-cysteine, and N-acetyl-L-cysteine) were able to partially reduce the  
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mitoNEET [2Fe-2S] clusters. Reduced glutathione appeared to reduce the mitoNEET [2Fe-2S] 
clusters with the least ability. L-cysteine are N-acetyl-L-cysteine were able to reduce about 50% 
of the mitoNEET [2Fe-2S] clusters in solution under anaerobic conditions, in comparison with the 
mitoNEET [2Fe-2S] clusters fully reduced by sodium dithionite. Further increasing L-cysteine 
concentration (up to 50 fold excess over the mitoNEET [2Fe-2S] clusters) or incubation time (up 
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to 60 minutes) did not increase the amount of the reduced mitoNEET [2Fe-2S] clusters in the 
incubation solution (data not shown), suggesting that L-cysteine could not fully reduce the 
mitoNEET [2Fe-2S] clusters under the experimental conditions. Interestingly, incubation with 
dithiothreitol, a dithiol that has an Em7 value of -323 mV (35), almost fully reduced the mitoNEET 
[2Fe-2S] clusters under the same experimental conditions (Figure 5.2). 
Human mitoNEET [2Fe-2S] clusters are fully reduced by the E. coli thioredoxin / thioredoxin 
reductase system 
 
 The biological equivalent of dithiothreitol is the ubiquitous thioredoxin (36). The Em7 value 
of E. coli thioredoxin is about -270 mV (37), which is close to that of dithiothreitol (35). To test 
whether the oxidized mitoNEET [2Fe-2S] clusters can be reduced by thioredoxin, we prepared E. 
coli thioredoxin and thioredoxin reductase as described previously (26). When purified mitoNEET 
[2Fe-2S] clusters were incubated with equimolar concentrations of the E. coli thioredoxin / 
thioredoxin reductase proteins or an excess amount of NADPH under anaerobic conditions, the 
mitoNEET [2Fe-2S] clusters remained in the oxidized state (Figure 5.3). This could be because 
purified thioredoxin is mostly oxidized during the protein purification process. Indeed, when 
purified mitoNEET [2Fe-2S] clusters were incubated with thioredoxin pre-reduced with 
thioredoxin reductase and NADPH, the mitoNEET [2Fe-2S] clusters were fully reduced (Figure 
5.3). On the other hand, the mitoNEET mutant H87C [2Fe-2S] clusters which have an Em7 of -320 
mV (11) could not be reduced by the E. coli thioredoxin / thioredoxin reductase system under the 
same experimental conditions (Figure 5.3). This is consistent with the observation that the 
mitoNEET mutant H87C [2Fe-2S] clusters are in the oxidized state when expressed in E. coli cells 
(Figure 5.1 B). Taken together, the results suggest that the wildtype mitoNEET [2Fe-2S] clusters 
can be fully reduced by the E. coli thioredoxin / thioredoxin system in vitro. 
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Reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen peroxide 
 Previous studies have shown that iron-sulfur clusters in regulatory proteins can undergo 
redox transition in response to oxidative signals without disruption of the clusters (38-41). To 
explore whether the mitoNEET [2Fe-2S] clusters may also act as a redox sensor to oxidative 
signals, we examined the stability of the mitoNEET [2Fe-2S] clusters under oxidative stress 
conditions. Figure 5.4 A shows that when purified mitoNEET [2Fe-2S] clusters were incubated 
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with increasing concentrations of hydrogen peroxide (up to 50 fold excess), the UV-visible 
absorption spectrum of the mitoNEET [2Fe-2S] clusters remained essentially unchanged, 
indicating that the mitoNEET [2Fe-2S] clusters are stable in the presence of hydrogen peroxide, 
yet are capable of being transiently oxidized.  
 We then questioned whether the pre-reduced mitoNEET [2Fe-2S] clusters can be oxidized 
by hydrogen peroxide. To avoid possible effects of NADPH on the stability of the mitoNEET 
[2Fe-2S] clusters (16), we pre-reduced the mitoNEET [2Fe-2S] clusters with excess dithiothreitol 
under anaerobic conditions. As shown in Figure 5.4 B, the pre-reduced mitoNEET [2Fe-2S] 
clusters were quickly oxidized upon addition of hydrogen peroxide. Further incubation with 
dithiothreitol after the hydrogen peroxide treatment led to a full re-reduction of the oxidized 
mitoNEET [2Fe-2S] clusters within about 14 minutes (Figure 5.4 B and C). The EPR 
measurements of the protein samples taken from the reaction solution further confirmed that the 
amount of the mitoNEET [2Fe-2S] clusters remain the same before and after the hydrogen 
peroxide treatment (Figure 5.4 D), suggesting that the mitoNEET [2Fe-2S] clusters can undergo 
redox transition in response to hydrogen peroxide without disruption of the clusters. 
 To further explore whether the mitoNEET [2Fe-2S] clusters could undergo redox transition 
in vivo in response to hydrogen peroxide, the E. coli cells expressing the mitoNEET [2Fe-2S] 
clusters were treated with hydrogen peroxide. As shown in Figure 5.5, addition of hydrogen 
peroxide (1 mM) to the E. coli cells largely eliminated the EPR signal at g = 1.94 of the reduced 
mitoNEET [2Fe-2S] clusters. Re-incubation of the E. coli cells in LB medium after the hydrogen 
peroxide treatment quickly restored the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] 
clusters, demonstrating that the mitoNEET [2Fe-2S] clusters can undergo redox transition in 
response to hydrogen peroxide in E. coli cells. 
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Type II diabetes drug pioglitazone inhibits the thiol-mediated reduction of the mitoNEET 
[2Fe-2S] clusters 
 
 It has been reported that binding of type II diabetes drug pioglitazone shifts the Em7 value 
of the mitoNEET [2Fe-2S] clusters by -100 mV (11). The negative shift of the Em7 value would 
make reduction of the mitoNEET [2Fe-2S] clusters more difficult. Nevertheless, how the redox 
state of the mitoNEET [2Fe-2S] clusters may be modulated by pioglitazone is unknown. With the 
finding that the mitoNEET [2Fe-2S] clusters can be reduced by biological thiols, we sought to 
investigate the effect of pioglitazone on the thiol-mediated reduction of the mitoNEET [2Fe-2S] 
clusters. Purified mitoNEET was pre-incubated with pioglitazone, followed by reduction with 
thiols under anaerobic conditions. Figure 5.6 A shows that binding of pioglitazone had little or no  
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effect on the dithionite-mediated reduction of the mitoNEET [2Fe-2S] clusters, as dithionite is a 
strong reductant (Em7 = -660 mV (27)). On the other hand, binding of pioglitazone largely inhibited 
the dithiothreitol-mediated reduction of the mitoNEET [2Fe-2S] clusters (Figure 5.6 B). The 
titration experiments show that as the concentration of pioglitazone was gradually increased in the 
incubation solutions (from 0 to 2.5 mM), the amount of the dithiothreitol-reduced mitoNEET [2Fe-
2S] clusters was progressively decreased (Figure 5.6 C). We also tested whether pioglitazone 
would affect the thioredoxin-mediated reduction of the mitoNEET [2Fe-2S] clusters in vitro. As 
shown in Figure 5.6 D, binding of pioglitazone greatly inhibited the thioredoxin-mediated 
reduction of the mitoNEET [2Fe-2S] clusters, suggesting that pioglitazone can effectively block 
the biological thiol-mediated reduction of the mitoNEET [2Fe-2S] clusters in cells. Nevertheless, 
attempts to modulate the redox state of the mitoNEET [2Fe-2S] clusters expressed in E. coli cells 
with pioglitazone were not successful. This is likely because pioglitazone may not easily penetrate 
bacterial cell walls and / or cell membranes, as addition of pioglitazone to the cell extracts prepared 
from the E. coli cells effectively inhibits the thiol-mediated reduction of the mitoNEET [2Fe-2S] 
clusters in the cell extracts (data not shown). 
 
5.4 Discussion 
 In this study, we report that human mitoNEET [2Fe-2S] clusters are fully reduced when 
expressed in E. coli cells under normal growth conditions, and that the clusters can be partially 
reduced by monothiols and fully reduced by dithiothreitol and the E. coli thioredoxin / thioredoxin 
reductase system in vitro. Importantly, the thiol-reduced mitoNEET [2Fe-2S] clusters can be 
reversibly oxidized by hydrogen peroxide without disruption of the clusters. Furthermore, binding 
of type II diabetes drug pioglitazone effectively blocks the thiol-mediated reduction of the 
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mitoNEET [2Fe-2S] clusters. The results suggest that the mitoNEET [2Fe-2S] cluster may act as 
a sensor of oxidative signals to regulate mitochondrial function and that the type II diabetes drug 
pioglitazone may modulate the function of mitoNEET by blocking the thiol-mediated reduction of 
the [2Fe-2S] clusters in cells. The possible interplay among biological thiols, hydrogen peroxide 
and type II diabetes drug pioglitazone in regulating the redox state of the mitoNEET [2Fe-2S] 
clusters is shown in Figure 5.7. 
 
 The interaction between thioredoxin and iron-sulfur clusters in proteins has been well 
established in ferredoxin-thioredoxin reductase where the reduced iron-sulfur clusters provide 
electrons for reduction of the oxidized thioredoxin (42,43). However, to the best of our knowledge, 
reduction of iron-sulfur clusters in proteins by biological thiols has not been previously reported. 
The unique ligand arrangement (Cys-72, Cys-74, Cys-83 and His-87) (8-10) and relatively high 
Em7 value (~0 mV) (11,12) may facilitate the reduction of the mitoNEET [2Fe-2S] clusters by 
biological thiols, as a single mutation (His-87 to cysteine) in mitoNEET shifts the Em7 value of the 
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[2Fe-2S] clusters from ~0 to -320 mV (11) and effectively prevents reduction of the clusters by 
biological thiols (Figure 5.3). Unlike NADPH which fails to reduce the mitoNEET [2Fe-2S] 
clusters in vitro (21), biological thiols have a relatively stable intermediate state of a thiol free 
radical (33,34) which can provide electrons for the single-electron reduction of the [2Fe-2S] 
clusters in mitoNEET. Interestingly, monothiols such as reduced glutathione, L-cysteine and N-
acetyl-L-cysteine can only partially reduce the mitoNEET [2Fe-2S] clusters even at high 
concentrations and with extended incubation time. On the other hand, dithiothreitol (Figure 5.2) 
and the E. coli thioredoxin pre-reduced with thioredoxin reductase and NADPH (Figure 5.3) can 
fully reduce the mitoNEET [2Fe-2S] clusters. The redox reactions underlying the reduction of the 
mitoNEET [2Fe-2S] clusters by biological thiols remain to be further investigated. Nevertheless, 
the finding that the reduced thioredoxin can reduce the mitoNEET [2Fe-2S] clusters is highly 
significant. Thioredoxin is highly conserved from bacteria to humans (36). In human cells, there 
are two major thioredoxins: thioredoxin 1, which is located in the cytosol and nucleus, and 
thioredoxin 2 located in mitochondria (44). The Em7 value of human cytosolic thioredoxin is about 
-230 mV (45), which is close to that of E. coli thioredoxin (-270 mV) (37). Thus, human 
thioredoxin could be responsible for reducing the mitoNEET [2Fe-2S] clusters. Because human 
thioredoxin has an essential role in regulation of complex diseases including cancer (46), 
cardiovascular disease, type II diabetes, and aging (47), the proposed role of human thioredoxin in 
reducing the mitoNEET [2Fe-2S] clusters may provide fresh clues for the links between 
thioredoxin and various human diseases. However, it should be pointed out that other biological 
thiols such as glutathione, L-cysteine, and glutaredoxins (48) may also reduce the mitoNEET [2Fe-
2S] clusters in cells. 
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 As a novel target of type II diabetes drug pioglitazone, mitoNEET has a specific interaction 
with pioglitazone (1). It has been speculated that pioglitazone may modulate energy metabolism 
in mitochondria via direct interaction with mitoNEET (49). Previous studies indicated that binding 
of pioglitazone stabilizes the [2Fe-2S] clusters in mitoNEET (10) and shifts the Em7 value of the 
[2Fe-2S] clusters from ~0 mV to -100 mV (11). Here, we find that binding of pioglitazone 
effectively inhibits the thiol-mediated reduction of the mitoNEET [2Fe-2S] clusters, likely due to 
the decreased Em7 value of the [2Fe-2S] clusters in the protein. Thus, pioglitazone may alter the 
function of mitoNEET by blocking the thiol-mediated reduction of the [2Fe-2S] clusters in cells. 
A set of novel ligands have recently been identified that may target mitochondrial mitoNEET 
(50,51). It would be of interest to explore the effect of these ligands on the thiol-mediated reduction 
of the mitoNEET [2Fe-2S] clusters. 
 The finding that the mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen 
peroxide without disruption of the clusters strongly suggests that the mitoNEET [2Fe-2S] cluster 
may act as a redox sensor to oxidative signals. The redox state of the [2Fe-2S] clusters in 
mitoNEET has already been attributed to regulate the iron-sulfur cluster transfer from mitoNEET 
to target proteins (20,21). It would be equally possible that the redox state of the [2Fe-2S] clusters 
may directly modulate energy metabolism in mitochondria via specific protein-protein interactions 
between mitoNEET and mitochondrial proteins such as pyruvate dehydrogenase in mitochondria 
(49). In crystal structural models, mitoNEET exists as a homodimer with two mitoNEET 
monomers tightly associated via the “beta cap” structure (8-10). The closest distance between the 
two [2Fe-2S] clusters in the mitoNEET dimer is about 14 Å. We envision that when the reduced 
[2Fe-2S] clusters are oxidized, two positive charges will be introduced to the mitoNEET dimer. 
The electrostatic repulsion between the two [2Fe-2S] clusters in the mitoNEET dimer could lead 
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to subtle conformation changes and consequently modulate mitochondrial functions. Similar redox 
regulation of iron-sulfur clusters has been proposed for a number of proteins (40). For example, in 
the redox transcription factor SoxR, oxidation of the [2Fe-2S] clusters switches on its transcription 
activity (38,41). In the bacterial DNA damage-inducible DNA helicase DinG, the enzyme is active 
only when the reduced [4Fe-4S] cluster is oxidized (39). In this context, we propose that 
mitoNEET may represent a new member of this redox signaling protein family in human cells. 
 Genome-wide searching revealed that humans have at least two mitoNEET related 
proteins: Miner1 (52) and Miner2 (2), which share the conserved CDGSH domain with mitoNEET 
(53). Miner1 was initially localized in the endoplasmic reticulum (54), but a recent study indicated 
that Miner1 is mostly associated with mitochondrial outer membrane (55). Mutations in the Miner1 
gene have been attributed to Wolfram Syndrome 2, a disease characterized by juvenile onset 
diabetes mellitus and optic atrophy (54). Biochemical studies have shown that Miner1 interacts 
with BCL2 (B-cell lymphoma 2) (56) and regulates sulfhydryl redox status, the unfolded protein 
response and Ca2+ homeostasis in mitochondria through an unknown mechanism (57). Like 
mitoNEET, Miner1 hosts a [2Fe-2S] cluster via an unusual three cysteine and one histidine 
residues in its C-terminal domain (52). While the function of Miner2 remains unknown, Miner2 is 
also located on mitochondrial outer membrane and most likely contains a [2Fe-2S] cluster hosted 
by three cysteine and one histidine residues (2). Existence of the [2Fe-2S] clusters in mitoNEET 
(7), Miner1 (52) and most likely in Miner2 (2) strongly suggests that the [2Fe-2S] clusters in this 
group of mitochondrial outer membrane proteins (53) may share similar and crucial regulatory 
functions. If the [2Fe-2S] clusters in Miner1 and Miner2, like that in mitoNEET, can be reduced 
by biological thiols and reversibly oxidized by hydrogen peroxide, Miner1 and Miner2 may also 
act as redox sensors to modulate specific functions in response to oxidative signals in human cells. 
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CHAPTER 6 
REDUCTION OF HUMAN MITOCHONDRIAL PROTEIN MITONEET [2FE-2S] 
CLUSTERS BY HUMAN GLUTATHIONE REDUCTASE 5 
 
6.1 Introduction 
 Thiazolidinediones (TZDs) such as pioglitazone are prescription drugs for patients with 
type II diabetes (1). While the primary target of TZDs is the peroxisome proliferator-activated 
receptor γ (PPARγ) which regulates the expression of the genes for fatty acid metabolism and 
insulin signaling pathways (2), TZDs also have the PPARγ-independent physiological effects on 
energy metabolism in mitochondria (3). This observation led to the discovery of the novel 
mitochondrial outer membrane protein mitoNEET, which specifically binds pioglitazone (4). 
Deletion of mitoNEET in mice decreases the oxidative phosphorylation capacity in mitochondria 
(5). On the other hand, increased expression of mitoNEET in adipocytes will enhance lipid uptake 
and storage and inhibit mitochondrial iron transport into the matrix (6), suggesting that mitoNEET 
may regulate energy metabolism in mitochondria (4). Recent studies further showed that 
mitoNEET has a central role in development of neurodegenerative diseases (7), breast cancer 
proliferation (8), TNFα-induced necroptosis in hepatocytes (9), and browning of white adipose 
tissue (10), among other pathological conditions (11).  
 Human mitoNEET is a homodimer with each monomer containing an N-terminal 
transmembrane α-helix (residues 14 to 32) tethered to mitochondrial outer membrane (5) and a C-
terminal cytosolic domain hosting a redox active [2Fe-2S] cluster via the unusual ligand 
arrangement of three cysteine (Cys-72, Cys-74 and Cys-83) and one histidine (His-87) residues 
                                                 
5 This chapter previously appeared as: Landry, A. P., Cheng, Z., and Ding, H. (2015) Reduction 
of mitochondrial protein mitoNEET [2Fe-2S] clusters by human glutathione reductase. Free 
radical biology & medicine 81, 119-127. Modified and reprinted with permission of Elsevier. 
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(12-15). While the specific function of mitoNEET has not been fully understood, several studies 
have suggested that mitoNEET may transfer its [2Fe-2S] clusters to apo-ferredoxin in vitro (16,17) 
or to the iron regulatory protein-1 (IRP-1) in vivo (18). Since mitochondria are the primary sites 
for iron-sulfur cluster biogenesis (19), it was compelling to suggest that mitoNEET may act as a 
carrier transporting iron-sulfur clusters assembled in mitochondria to target proteins in cytoplasm 
(16-18). Nevertheless, the observed cluster transfer occurs only when the mitoNEET [2Fe-2S] 
clusters are in oxidized state (16). Since the redox midpoint potential of the mitoNEET [2Fe-2S] 
clusters (Em7) is ~0 mV (20,21) and the cytosolic redox potential is ~ -325 mV (pH 7.0) (22), the 
mitoNEET [2Fe-2S] clusters are mostly in the reduced state in cells under normal physiological 
conditions (23). Thus, mitoNEET may transfer its iron-sulfur clusters to target proteins only when 
cells are under oxidative stress conditions (16). 
 Alternatively, mitoNEET may directly regulate energy metabolism in mitochondria via its 
redox active [2Fe-2S] clusters (20,23). It has already been reported that the redox property of the 
mitoNEET [2Fe-2S] clusters can be modulated by pH (21), inter-domain interactions (24,25), 
hydrogen bond network (26), type II diabetes drug pioglitazone (20), and NADP+/NADPH 
(17,27). Recent proteomic studies further suggested that mitoNEET may form complexes with 
proteins that are crucial in aging, diabetes, and neurodegenerative diseases (28,29). Thus, the 
mitoNEET [2Fe-2S] cluster may act as a sensor of multiple cellular signals to regulate 
mitochondrial functions through specific protein-protein interactions. In previous studies, we 
reported that the mitoNEET [2Fe-2S] clusters are fully reduced when expressed in Escherichia 
coli cells, and that purified mitoNEET [2Fe-2S] clusters can be reduced by dithiothreitol or the E. 
coli thioredoxin/thioredoxin reductase system (23). However, specific components that reduce or 
oxidize the mitoNEET [2Fe-2S] clusters in mammalian cells have not been identified. Here, we 
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find that human mitoNEET [2Fe-2S] clusters can be efficiently reduced by E. coli thioredoxin 
reductase and glutathione reductase in an NADPH-dependent reaction. Purified human glutathione 
reductase (30) has the same activity as E. coli glutathione reductase to reduce the mitoNEET [2Fe-
2S] clusters. However, rat thioredoxin reductase, a human thioredoxin reductase homolog that 
contains an unusual selenocysteine residue (U498) in the catalytic center (31-33), has very little or 
no activity to reduce the mitoNEET [2Fe-2S] clusters. N-ethylmaleimide, a potent modifier of 
redox active thiols in human glutathione reductase (34), completely inhibits the enzyme to reduce 
the mitoNEET [2Fe-2S] clusters, indicating that the redox active disulfide in the catalytic center 
of human glutathione reductase may be directly involved in reducing the mitoNEET [2Fe-2S] 
clusters. Additional studies show that the reduced mitoNEET [2Fe-2S] clusters in the mouse heart 
cell extracts can be reversibly oxidized by hydrogen peroxide. The results led us to propose that 
the mitoNEET [2Fe-2S] clusters may act as a novel redox sensor to modulate energy metabolism 
in mitochondria in response to oxidative signals. 
 
6.2 Materials and Methods 
Protein preparation 
 A DNA fragment encoding human mitoNEET33–108 (containing amino acid residues 33-
108) was synthesized (Genscript) and cloned into pET28b+. Recombinant mitoNEET was 
expressed in the E. coli BL21(DE3) strain and purified as described previously (23,35). E. coli 
thioredoxin reductase (36), glutathione reductase (37), succinic semialdehyde dehydrogenase (38), 
and 2,4-dienoyl-CoA reductase (39) were prepared using the E. coli strains from the ASKA library 
(40). Recombinant human glutathione reductase was prepared using the plasmid pUB302 (kindly 
provided by Professor Katja Becker, Justus Liebig University, Germany) in an E. coli strain SG5 
(in which gene gor encoding glutathione reductase was deleted) (41). E. coli strain SG5 cells 
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hosting pUB302 were grown in LB medium at 37°C for 5 hours without inducers, harvested, and 
disrupted by passing through French press once. The crude cell extracts were centrifuged at 12,000 
x g for 30 minutes at 4°C to remove cell debris. The supernatant was dialyzed against 20 mM Tris 
(pH 8.0) for 5 hours at 4°C. The dialyzed sample was supplemented with 1 mM oxidized 
glutathione (GSSG) and loaded onto an ADP-Sepharose column and washed with 0.3 M NaCl. 
Human glutathione reductase was then eluted from the column with 0.8 M NaCl and stored in 0.5 
M NaCl. The purity of purified proteins was greater than 95% as judged by SDS-PAGE analysis 
on a 15% polyacrylamide gel followed by staining with Coomassie Blue. The protein 
concentrations of human mitoNEET, E. coli thioredoxin reductase, E. coli glutathione reductase, 
and human glutathione reductase were measured at 280 nm using an extinction coefficient of 8.6, 
17.7, 38.2, and 34.9 mM-1cm-1, respectively. Native rat liver thioredoxin reductase was purchased 
from Sigma. Recombinant rat thioredoxin reductase (containing the native selenocysteine in the 
catalytic center) (42) was purchased from Cayman Chemical. 
Cell extracts preparation from E. coli cells and mouse heart 
 Wildtype E. coli BL21(DE3) cells were grown in LB medium at 37°C under aerobic 
conditions to O.D. at 600 nm of 1.0. Cells were harvested, washed with buffer containing NaCl 
(500 mM) and Tris (20 mM, pH 8.0), and passed through French press once. After centrifugation 
at 8,000 x g for 30 minutes at 4°C to remove cell debris, the resulting supernatant was passed 
through a HiTrap desalting column (GE Lifesciences). For the mouse heart cell extracts, hearts 
from wildtype mice (C57BL/6J, 3-4 weeks old, obtained from Pennington Biomedical Research 
Center, Louisiana State University) were rinsed in PBS buffer and minced with scissors. Heart 
tissues were ground with a homogenizer and further disrupted by drawing and ejecting samples 
using a syringe with a 26-gauge needle. Cell debris were removed by centrifugation at 8,000 x g 
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for 20 minutes at 4°C, and the resulting supernatant was used for the experiments. The protein 
concentration of the prepared cell extracts was determined using Bradford assay (43). 
Analyses of the redox state of mitoNEET [2Fe-2S] clusters 
 Purified human mitoNEET dissolved in buffer containing NaCl (500 mM) and Tris (20 
mM, pH 8.0) in a sealed vial was purged with pure argon gas for 15 minutes. The prepared cell 
extracts or enzymes were also purged with pure argon gas before transferred to the sealed vials 
using a gas-tight Hamilton syringe. The reaction solutions were then incubated in a 37°C water 
bath for the indicated time before the samples were analyzed by using the Beckman DU640 UV-
visible spectrophotometer or EPR. For the N-ethylmaleimide (NEM) treatments, purified human 
glutathione reductase or the mouse heart cell extracts were pre-incubated with NEM (2 mM) and 
NADPH (0.2 mM) at room temperature for 3 hours to irreversibly modify the redox active thiols 
in the proteins. 
EPR measurements 
 The X-band EPR (electron paramagnetic resonance) spectra were recorded using a Bruker 
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow cryostat. 
Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power, 10.0 mW; 
modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30 K; receive gain, 
2 x 105. The amount of the reduced mitoNEET [2Fe-2S] clusters was quantified as in (23). 
Chemicals 
 Isopropyl β-D-1-thiogalactopyranoside, NADPH, kanamycin, ampicillin, and 
dithiothreitol were purchased from Research Products International. Pioglitazone, reduced 
glutathione, oxidized glutathione, N-ethylmaleimide, hydrogen peroxide, and other chemicals 
were purchased from Sigma. 
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6.3 Results 
Reduction of the mitoNEET [2Fe-2S] clusters by E. coli thioredoxin reductase and 
glutathione reductase 
 
 When recombinant human mitoNEET was expressed in E. coli cells, the mitoNEET [2Fe-
2S] clusters were fully reduced (23), indicating that E. coli cells have a robust activity to reduce 
the mitoNEET [2Fe-2S] clusters. To search for the cellular components that are responsible for 
reducing the human mitoNEET [2Fe-2S] clusters, we prepared cell extracts from exponentially 
growing E. coli cells. Figure 6.1 A shows that while NADPH (spectrum 2) or the E. coli cell 
extracts (spectrum 3) had no activity to reduce the human mitoNEET [2Fe-2S] clusters, addition 
of NADPH to the cell extracts quickly reduced the mitoNEET [2Fe-2S] clusters (spectrum 4) 
which had a typical rhombic EPR signal at g = 1.94 (12,23,26). The amplitude of the EPR signal 
at g = 1.94 of the mitoNEET [2Fe-2S] clusters in the E. coli cell extracts (spectrum 4) was 
essentially the same as that when the mitoNEET protein was reduced with sodium dithionite 
(spectrum 5), indicating that the mitoNEET [2Fe-2S] clusters are fully reduced in the E. coli cell 
extracts by NADPH. 
 Since the mitoNEET [2Fe-2S] clusters can be reduced by excess dithiothreitol in vitro (23), 
we reasoned that the mitoNEET [2Fe-2S] clusters may be reduced by reduced thioredoxin (23) or 
the enzymes that contain a redox active disulfide in vivo. In E. coli, there are at least two reductases: 
thioredoxin reductase (44) and glutathione reductase (37), that have a redox active disulfide in the 
catalytic center. To test this idea, we prepared E. coli thioredoxin reductase and glutathione 
reductase as described in the Materials and Methods. Purified E. coli thioredoxin reductase and 
glutathione reductase had a similar UV-visible absorption spectrum (Figure 6.1 B), indicative of 
the protein-bound FAD cofactor as reported previously (37,44).  
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Figure 6.1. MitoNEET [2Fe-2S] clusters are reduced by E. coli thioredoxin reductase and glutathione 
reductase. A, EPR spectra of the mitoNEET [2Fe-2S] clusters in the E. coli cell extracts. Purified mitoNEET 
(10 μM [2Fe-2S] clusters; spectrum 1) was incubated with NADPH (50 μM; spectrum 2), the E. coli cell 
extracts (4 mg/ml of total protein; spectrum 3), or NADPH (50 μM) and the E. coli cell extracts (4 mg/ml 
of total protein; spectrum 4) at 37°C for 20 min under anaerobic conditions. Spectrum 5, purified mitoNEET 
(10 μM [2Fe-2S] clusters) reduced with 2 mM sodium dithionite. The EPR signal at g = 1.94 represents the 
reduced mitoNEET [2Fe-2S] clusters. B, Purified E. coli thioredoxin reductase and glutathione reductase. 
Spectrum 1, UV-visible absorption spectrum of purified E. coli thioredoxin reductase (eTrxB). Spectrum 
2, UV-visible absorption spectrum of purified glutathione reductase (eGor). eTrxB and eGor shown in B 
contained about 15 μM FAD. Inset is a photograph of the SDS-PAGE of purified E. coli thioredoxin 
reductase (lane 1) and glutathione reductase (lane 2). C, Reduction of the mitoNEET [2Fe-2S] clusters by E. 
coli thioredoxin reductase and glutathione reductase. Purified mitoNEET (10 μM [2Fe-2S] clusters; 
spectrum 1) was incubated with NADPH (50 μM; spectrum 2), eTrxB (1 μM; spectrum 3), eGor (1 μM; 
spectrum 4), E. coli thioredoxin  reductase (1 μM) and NADPH (50 μM; spectrum 5), or E. coli glutathione 
reductase (1 μM) and NADPH (50 μM; spectrum 6) at 37°C for 20 min  under anaerobic conditions. The 
EPR signal at g = 1.94 represents the reduced mitoNEET [2Fe-2S] clusters. The results are representatives 
of three independent experiments. 
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 Figure 6.1 C shows that purified E. coli thioredoxin reductase (spectrum 3) or glutathione 
reductase (spectrum 4) had no activity to reduce the mitoNEET [2Fe-2S] clusters. However, when 
mitoNEET was incubated with E. coli thioredoxin reductase and NADPH (spectrum 5) or E. coli 
glutathione reductase and NADPH (spectrum 6) at 37°C for 20 minutes under anaerobic 
conditions, the mitoNEET [2Fe-2S] clusters were fully reduced, suggesting that both E. coli 
thioredoxin reductase and glutathione reductase are able to reduce the mitoNEET [2Fe-2S] clusters 
in the presence of NADPH. In parallel, we also prepared two NADPH-dependent reductases: 
succinic semialdehyde dehydrogenase (38) and 2,4-dienoyl-CoA reductase (39) from E. coli cells. 
Both enzymes use NADPH as a substrate but do not contain the redox active disulfide in the 
catalytic center. Under the same experimental conditions, E. coli succinic semialdehyde 
dehydrogenase and 2,4-dienoyl-CoA reductase had no activity to reduce the mitoNEET [2Fe-2S] 
clusters in the presence of NADPH (data not shown). Thus, E. coli thioredoxin reductase and 
glutathione reductase activity in reducing the human mitoNEET [2Fe-2S] clusters is specific. 
Reduction of the mitoNEET [2Fe-2S] clusters by human glutathione reductase 
 In humans, there are three thioredoxin reductases: a cytosolic form (45), a mitochondrial 
form (46), and a thioredoxin / glutathione reductase in the microsomal fraction of testis tissue (47). 
As mitoNEET localizes on mitochondrial outer membrane (5), it is most likely that cytosolic 
thioredoxin reductase would be responsible for reducing the mitoNEET [2Fe-2S] clusters. Like E. 
coli thioredoxin reductase, human cytosolic thioredoxin reductase contains FAD and an NADPH 
binding site (32,33,48). However, unlike E. coli thioredoxin reductase, human thioredoxin 
reductase has an unusual selenocysteine residue (U498) in the catalytic center (31-33). As native 
human cytosolic thioredoxin reductase was not readily available, we used rat thioredoxin reductase 
which has 91% identity and 96% similarity to human thioredoxin reductase and contains the 
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selenocysteine residue in the catalytic center. Rat liver thioredoxin reductase (from Sigma) was 
fully active to reduce 5,5´-dithiobis-(2-nitrobenzoic acid) (DTNB). However, unlike E. coli 
thioredoxin reductase, rat liver thioredoxin reductase had very little or no activity to reduce the 
mitoNEET [2Fe-2S] clusters (data not shown). We also obtained recombinant rat thioredoxin 
reductase (from Cayman Chemical) which also contains the selenocysteine residue and is fully 
active to reduce DTNB (42). As before, recombinant rat thioredoxin reductase failed to reduce the 
mitoNEET [2Fe-2S] clusters in the presence of NADPH (Figure 6.2 B, spectrum 2). 
 Human glutathione reductase is a major cellular reductase that reduces the oxidized 
glutathione in cytosol (30,41). Unlike human thioredoxin reductase, human glutathione reductase 
does not have selenocysteine in the catalytic center. Thus, we prepared recombinant human 
glutathione reductase from E. coli cells following the procedures described in (41). Purified human 
glutathione reductase had a similar UV-visible absorption spectrum as E. coli glutathione reductase 
(Figure 6.2 A), and similar activity to reduce the mitoNEET [2Fe-2S] clusters in the presence of 
NADPH (Figure 6.2 B, spectra 3 and 4). Therefore, in human cells, glutathione reductase is at least 
one protein able to reduce the mitoNEET [2Fe-2S] clusters in an NADPH-dependent reaction. 
 Pioglitazone, a type II diabetes drug, has been shown to shift the redox midpoint potential 
(Em7) of the mitoNEET [2Fe-2S] clusters by ~ -100 mV (20). The negative shift of the Em7 value 
would make it more difficult to reduce the mitoNEET [2Fe-2S] clusters. It would be of interest to 
know whether pioglitazone affects the human glutathione reductase-mediated reduction of the 
mitoNEET [2Fe-2S] clusters. Thus, mitoNEET was pre-incubated with pioglitazone before being 
reduced with human glutathione reductase and NADPH. As shown in Figure 6.2 B, the mitoNEET 
[2Fe-2S] clusters were only partially inhibited (spectrum 5) upon binding of pioglitazone. The 
result is consistent with the notion that binding of pioglitazone to mitoNEET negatively shifts the  
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Em7 of the mitoNEET [2Fe-2S] clusters (20,23) and impedes reduction of the mitoNEET [2Fe-2S] 
clusters by glutathione reductase. 
 The oxidized mitoNEET [2Fe-2S] clusters have two major UV-visible absorption peaks at 
458 nm and 540 nm (12). When the mitoNEET [2Fe-2S] clusters are reduced, the absorption peak 
at 458 nm is changed to 420 nm (23). Here, we took advantage of these distinct UV-visible 
absorption peaks of the mitoNEET [2Fe-2S] clusters to explore the reduction kinetics of the 
mitoNEET [2Fe-2S] clusters by human glutathione reductase. When mitoNEET was incubated 
with a catalytic amount of human glutathione reductase in the presence of NADPH at 37°C under 
anaerobic conditions, the absorption peak at 458 nm of the oxidized mitoNEET [2Fe-2S] clusters 
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was quickly decreased and replaced with the absorption peak at 420 nm of the reduced mitoNEET 
[2Fe-2S] clusters (Figure 6.3 A). The amount of the reduced mitoNEET [2Fe-2S] clusters in the 
reaction solution was plotted as a function of incubation time. Under the experimental conditions, 
the mitoNEET [2Fe-2S] clusters were fully reduced by 20 minutes with a half-reduction time of 
less than 5 minutes (Figure 6.3 B). 
 
The redox active disulfide center in human glutathione reductase is involved in reducing the 
mitoNEET [2Fe-2S] clusters 
 
 Human glutathione reductase catalyzes the reduction of oxidized glutathione (GSSG) to 
reduced glutathione (GSH) using NADPH as electron donor (30,41). If glutathione reductase 
reduces the mitoNEET [2Fe-2S] clusters at the same catalytic site where GSSG is reduced, we 
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would expect competition between GSSG and the mitoNEET [2Fe-2S] clusters for the catalytic 
center in the enzyme. To test this idea, we explored the effect of GSSG on the glutathione 
reductase-mediated reduction of the mitoNEET [2Fe-2S] clusters. Figure 6.4 A shows that in the 
absence of GSSG, the mitoNEET [2FE-2S] clusters (10 μM) were fully reduced by 10 μM NADPH  
in the presence of a catalytic amount of human glutathione reductase. In the presence of 10 μM 
GSSG, however, the mitoNEET [2Fe-2S] clusters were reduced only after 20 μM NADPH was 
added in the incubation solution (Figure 6.4 B). Thus, GSSG may effectively block the human 
glutathione reductase-mediated reduction of the mitoNEET [2Fe-2S] clusters by competing for the 
same catalytic center in the enzyme (Figure 6.4 C). 
 Unlike E. coli thioredoxin reductase and glutathione reductase (Figure 6.1 C) or human 
glutathione reductase (Figure 6.2 B), rat thioredoxin reductase has very little or no activity to 
reduce the mitoNEET [2Fe-2S] clusters (Figure 6.2 B). One possible explanation is that rat 
thioredoxin reductase has an unusual selenocysteine in the catalytic center (31-33), which fails to 
reduce the mitoNEET [2Fe-2S] clusters. If that is the case, we would expect that modification of 
the redox active disulfide in the catalytic center of human glutathione reductase may inhibit the 
enzyme activity to reduce the mitoNEET [2Fe-2S] clusters. 
 N-ethylmaleimide (NEM), a potent thiol modifier, has been used to inhibit human 
glutathione reductase (34,49). Figure 6.4 D shows that the NEM-treated human glutathione 
reductase failed to reduce the mitoNEET [2Fe-2S] clusters (spectrum 2). However, addition of 
sodium dithionite to the above reaction solution quickly restored the EPR signal at g = 1.94 of the 
mitoNEET [2Fe-2S] clusters (spectrum 3), suggesting that NEM inhibits human glutathione 
reductase to reduce the mitoNEET [2Fe-2S] clusters without directly modifying the mitoNEET 
[2Fe-2S] clusters or the protein itself to inhibit reduction. Thus, the redox active disulfide in the  
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catalytic center of human glutathione reductase may be directly involved in in reducing the 
mitoNEET [2Fe-2S] clusters. 
The mitoNEET [2Fe-2S] clusters are fully reduced in the mouse heart cell extracts by 
NADPH 
 
 As human glutathione reductase can efficiently reduce the mitoNEET [2Fe-2S] clusters in 
an NADPH-dependent reaction (Figure 6.3), the mitoNEET [2Fe-2S] clusters may also be reduced 
in mammalian cells by glutathione reductase or similar enzymes. To test this idea, we prepared 
cell extracts from mouse heart as described in the Materials and Methods. Figure 6.5 A shows that 
while the mouse heart cell extracts had no activity to reduce the mitoNEET [2Fe-2S] clusters 
(spectrum 2), addition of NADPH to the cell extracts reduced the mitoNEET [2Fe-2S] clusters 
(spectrum 3) with the EPR amplitude similar to that reduced with sodium dithionite (spectrum 4). 
 The cell extracts were then treated with the thiol modifier NEM to inactivate glutathione 
reductase or similar enzymes. As shown in Figure 6.5 B, the NEM-treated cell extracts had no 
activity to reduce the mitoNEET [2Fe-2S] clusters in the presence of NADPH (spectrum 3). 
Nevertheless, addition of sodium dithionite to the NEM-treated cell extracts immediately restored 
the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] clusters (spectrum 4), suggesting 
that NEM inhibits the cellular reductase activities without affecting on the mitoNEET [2FE-2S] 
clusters in the mouse heart cell extracts. 
Reduced mitoNEET [2Fe-2S] clusters in the cell extracts are transiently oxidized by 
hydrogen peroxide 
 
 To examine whether the mitoNEET [2Fe-2S] clusters may undergo redox transition in 
response to oxidative signals, we treated mouse heart cell extracts containing the pre-reduced 
mitoNEET [2Fe-2S] clusters with different amounts of hydrogen peroxide. As the concentration  
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of hydrogen peroxide in the cell extracts was increased from 0 to 200 μM, the reduced mitoNEET 
[2Fe-2S] clusters were gradually oxidized (Figure 6.6 A). About 100 μM hydrogen peroxide was 
sufficient to completely oxidize 5 μM mitoNEET [2Fe-2S] clusters in the cell extracts (Figure 6.6 
B). Importantly, addition of sodium dithionite to the hydrogen peroxide-treated cell extracts 
quickly restored the EPR signal at g = 1.94 of the reduced mitoNEET [2Fe-2S] clusters (Figure 
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6.6 A), suggesting that hydrogen peroxide oxidizes the mitoNEET [2Fe-2S] clusters without 
disrupting the clusters in the protein. 
 We then asked whether oxidation of the mitoNEET [2Fe-2S] clusters by hydrogen peroxide 
is reversible in the mouse heart cell extracts. In the experiment, the mitoNEET [2Fe-2S] clusters 
oxidized by hydrogen peroxide in the cell extracts with excess NADPH were re-incubated at 37°C 
under anaerobic conditions. As shown in Figure 6.7, the oxidized mitoNEET [2Fe-2S] clusters in 
the cell extracts were almost fully re-reduced within about 30 minutes of re-incubation after the 
initial oxidation of the clusters by hydrogen peroxide. 
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6.4 Discussion 
 Human mitoNEET is a small mitochondrial outer membrane protein containing a redox 
active [2Fe-2S] cluster. Here we find that the mitoNEET [2Fe-2S] clusters can be efficiently 
reduced by human glutathione reductase in an NADPH-dependent reaction. On the other hand, rat 
thioredoxin reductase, a homolog of human thioredoxin reductase, has very little or no activity to 
reduce the mitoNEET [2Fe-2S] clusters. Oxidized glutathione appears to compete for the catalytic 
site of human glutathione reductase and effectively inhibits the enzyme-mediated reduction of the 
mitoNEET [2Fe-2S] clusters, indicating a potential dynamic link between the redox state of the 
138 
 
mitoNEET [2Fe-2S] clusters and the ratio of oxidized glutathione to reduced glutathione in cells. 
Additional studies further revealed that the reduced mitoNEET [2Fe-2S] clusters in the mouse 
heart cell extracts can be transiently oxidized by hydrogen peroxide without disruption of the 
clusters in the protein. The results suggest that the mitoNEET [2Fe-2S] clusters may undergo redox 
transition to regulate energy metabolism in mitochondria in response to oxidative signals.  
 The finding that human glutathione reductase (30) can reduce the mitoNEET [2Fe-2S] 
clusters (Figure 6.2 B) is novel. While the underlying mechanism is not immediately clear, it seems 
that the redox active disulfide in the catalytic center of human glutathione reductase has a crucial 
role in reducing the mitoNEET [2Fe-2S] clusters. Both E. coli thioredoxin reductase (44) and 
glutathione reductase (37) contain redox active disulfide in the catalytic center and have the same 
activity to reduce the mitoNEET [2Fe-2S] clusters (Figure 6.1). In contrast, rat thioredoxin 
reductase, a homolog of human thioredoxin reductase that contains an unusual selenocysteine in 
the catalytic center (31-33), has very little or no activity to reduce the mitoNEET [2Fe-2S] clusters 
(Figure 6.2 B). E. coli succinic semialdehyde dehydrogenase (38) and 2,4-dienoyl-CoA reductase 
(39), which use NADPH as substrate but do not have a redox active disulfide in the catalytic center, 
also fail to reduce the mitoNEET [2Fe-2S] clusters (data not shown). Furthermore, modification 
of the redox active disulfide in human glutathione reductase by thiol modifier NEM (34,49) 
completely inhibits the enzyme activity to reduce the mitoNEET [2Fe-2S] clusters (Figures 6.4 
and 6.5). Taken together, we conclude that the redox active disulfide in the catalytic center of 
human glutathione reductase may be directly involved in reducing the mitoNEET [2Fe-2S] clusters 
(Figure 6.8). 
 While the mechanism for reduction of dithiol by iron-sulfur cluster in proteins has been 
extensively investigated in plant ferredoxin-thioredoxin reductase (50), the reverse reaction 
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(reduction of iron-sulfur cluster in proteins by monothiol) is essentially unknown. Interestingly, 
Fridovich’s group previously reported that E. coli thioredoxin reductase may produce superoxide 
by transferring a single electron to dioxygen (51). Perhaps, E. coli thioredoxin reductase utilizes 
similar mechanism to reduce the mitoNEET [2Fe-2S] clusters (Figure 6.1 C). More recently, 
Buckel’s group showed that butyryl-CoA dehydrogenase from Acidaminococcus fermentans, a 
FAD-containing enzyme, can reduce the ferredoxin [4Fe-4S] cluster and crotonyl-CoA 
simultaneously (52) in a bifurcation reaction (53). FAD acts as an electron gate to deliver one 
electron at a time for reduction of the ferredoxin [4Fe-4S] cluster and crotonyl-CoA in butyryl-
CoA dehydrogenase (52). As human glutathione reductase also contains FAD (Figure 6.2 A), we 
propose that during the reaction cycle, an intermediate state of FADH- coupled with the redox 
active disulfide formed in human glutathione reductase (30) may deliver single electrons to reduce 
the mitoNEET [2Fe-2S] clusters (Figure 6.8). 
 Under normal physiological conditions, the mitoNEET [2Fe-2S] clusters are mostly in 
reduced state in vivo (23) (Figure 6.5). However, when cells are under oxidative stress or during 
apoptosis and differentiation, the intracellular redox potential could increase from -325 mV (pH 
7.0) (22) to as high as +200 mV (54), which would result in oxidation of the mitoNEET [2Fe-2S] 
clusters. The closest distance between two [2Fe-2S] clusters in the mitoNEET dimer is about 14 
Å (13-15). Thus, oxidation of the two [2Fe-2S] clusters in the mitoNEET dimer may result in 
confirmation change of the mitoNEET dimer via electric repulsion. Since mitoNEET can 
potentially form protein complexes with E3 ubiquitin ligase Parkin (28), V-ATPase (29), tax-
responsive enhancer element-binding protein 107 (RPL6) (29), translocase of outer mitochondrial 
membrane 7 homolog (TOMM7) (29), mitochondrial outer membrane import complex protein 1 
(MTX1) (29), polyubiquitin-C (UBC) (55), and glutamate dehydrogenase 1 (56), we postulate that  
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mitoNEET may modulate the functions of its binding partners in mitochondria via redox transition 
of its [2Fe-2S] clusters in response to redox signals.  
 MitoNEET-like proteins are widely distributed in the three domains of life (57-59). In 
humans, there are two mitoNEET-like proteins: Miner1 (60) and Miner2 (5). Like mitoNEET, the 
C-terminal domain of Miner1 hosts a redox active [2Fe-2S] cluster via three cysteine and one 
histidine residues (60). Mutations in Miner1 have been attributed to Wolfram Syndrome 2, a 
disease characterized by juvenile onset diabetes mellitus and optic atrophy (61). Miner1 was 
initially localized on endoplasmic reticulum (61), but recent studies indicated that Miner1 also 
localizes on mitochondrial outer membrane (62,63) and has a crucial role in regulating sulfhydryl 
redox status, the unfold protein response, and Ca2+ homeostasis in mitochondria via a yet unknown 
regulatory mechanism (63). While the physiological function of Miner2 remains unknown, Miner2 
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is also a mitochondrial outer membrane protein (5) hosting two [2Fe-2S] clusters per monomer 
(unpublished results). It may be envisioned that human mitoNEET, Miner1, and Miner2 may 
modulate different functions on mitochondria via redox transition of the [2Fe-2S] clusters. 
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CHAPTER 7 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Iron-sulfur cluster biogenesis is comprised of a complex protein system that first requires 
the acquisition of sulfur and iron. The source of sulfur for iron-sulfur cluster assembly in E. coli is 
provided by the cysteine desulfurase IscS, which extracts sulfide from L-cysteine. However, an 
iron donor for the iron-sulfur cluster assembly process has not been established. Previous evidence 
suggests that IscA could participate as the iron donor for iron-sulfur cluster assembly (1). Here, 
we have demonstrated that among the basal iron-sulfur cluster assembly machinery of IscS, IscU 
and IscA and co-chaperones HscB and HscA, significant iron content was only detected in IscA 
after purification from E. coli cells, and the iron content of IscA was increased by reconstitution 
with ferrous iron. Previously, L-cysteine was found to extract iron from IscA (2). In this study, the 
iron release from IscA was found to be a two-step mechanism of 1) L-cysteine-mediated extraction 
of Fe3+ from IscA and 2) L-cysteine-mediated reduction of Fe3+ to Fe2+ for use in the iron-sulfur 
cluster assembly process. IscA contains a 3-cysteine binding pocket which can either harbor iron 
or an iron-sulfur cluster (3,4). However, we also investigated IscA tyrosine 40 (Y40) as a potential 
oxygenic ligand for iron binding (5). Mutation of tyrosine 40 to phenylalanine (Y40F) greatly 
diminished iron binding in IscA. Interestingly, IscA Y40F can still assemble iron sulfur clusters 
but fails to rescue the null growth phenotype in iscA-/sufA- mutant E. coli cells. Thus, iron-sulfur 
cluster binding in IscA is dispensable for its function, but iron binding in IscA is required in vivo. 
 Recently, iscA-/sufA- mutant E. coli cells were found to generate a unique red-colored IscS, 
and this species was also formed by depleting wildtype E. coli cells of iron (6). This indicated that 
red IscA that may represent a reaction intermediate, and suggested that iron binding in IscA is 
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required for proper IscS function. Investigating other reaction intermediates in the iron-sulfur 
cluster assembly process will be the next step in determining the function of iron-bound IscA. 
 Iron-sulfur proteins are susceptible to nitric oxide (NO), which modifies the iron-sulfur 
cluster and can compromise protein function. NO modification of iron-sulfur clusters results in the 
formation of intracellular dinitrosyl iron complexes (DNICs). However, the protein source of in 
vivo DNIC formation was unclear. Here, we demonstrated that the DNICs generated in the cell are 
concomitant with the presence of iron-sulfur proteins, as expression of recombinant iron-sulfur 
proteins in E. coli cells significantly increased DNICs formed after NO treatment. In contrast, 
recombinant proteins that do not contain iron-sulfur clusters did not contribute to DNICs formed 
after NO treatment. Furthermore, E. coli iscA-/sufA- double mutant cells generated very little 
DNICs after NO treatment compared to wildtype cells, and DNIC formation in the mutant was not 
increased by the expression of recombinant iron-sulfur proteins. Chelating iron from E. coli cells 
resulted in loss of iron-sulfur clusters from cells and diminished DNIC formation after NO 
treatment. Deficiency of iron-sulfur clusters was also found to decrease chelatable iron in the iscA-
/sufA- double mutant cells. Taken together, these results show that iron-sulfur proteins are a 
significant source of intracellular chelatable iron and may be a primary target of NO cytotoxicity. 
 As iron-sulfur proteins are the primary source of DNICs formed from NO stress, it would 
be intriguing to investigate the specific iron-sulfur proteins modified by NO in vivo. Previous 
studies from our lab have demonstrated a broad distribution of DNICs in proteins fractionated from 
E. coli cell extract (7). DNIC modification may also be very dynamic depending on the level of 
NO exposure to cells, as some iron-sulfur clusters react with NO with higher affinity than others 
(8). Thus, exploring the iron-sulfur cluster proteins modified by NO in vivo could provide insight 
into the specific protein targets of NO cytotoxicity. 
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Several diseases have been attributed to dysfunctional iron-sulfur proteins including Rtel1, 
a DNA helicase that maintains telomere length. Rtel1 was predicted to contain an iron-sulfur 
cluster that may modulate its helicase activity similar to E. coli DinG, a redox active [4Fe-4S] 
DNA damage-inducible helicase (9). Here, we have identified a [4Fe-4S] cluster in the N-terminal 
domain of Rtel1 (RtelN). The cluster is redox-active with a redox midpoint potential of -248 ± 10 
mV, suggesting the cluster may be in the reduced state in vivo. RtelN also retains weak binding 
affinity for both single-stranded and double-stranded DNA. The [4Fe-4S] cluster was sensitive to 
destruction by both hydrogen peroxide and NO modification, although neither affected the DNA 
binding activity. From the results, we speculate that Rtel1 may have a redox-dependent activity 
similar to DinG, in which the reduced [4Fe-4S] cluster can be oxidized to activate helicase activity.  
Although a redox-active [4Fe-4S] cluster is present, the function of the cluster in Rtel1 
helicase activity remains to be determined. Our attempts to purify Rtel1 were restricted by its low 
solubility when expressed as a full-length recombinant protein in E. coli; thus, any further 
characterization of Rtel1 will require the development of a novel purification process. If soluble 
protein can be attained, it can readily be assayed for redox-dependent helicase activity. Telomeres 
are more susceptible to oxidative stress than other chromosomal DNA (10); thus, elucidating a 
redox-dependent helicase mechanism in Rtel1 would reveal a new link between telomere 
breakdown, oxidative stress, and aging. 
The human [2Fe-2S] protein MitoNEET is a binding target of the type II diabetes drug 
pioglitazone (11) and has implications in mitochondrial metabolism and diabetes. However, the 
functional role for mitoNEET is unclear. Here, we have demonstrated that when expressed in E. 
coli cells, the mitoNEET [2Fe-2S] clusters are in the reduced state. In vitro, the oxidized 
mitoNEET [2Fe-2S] cluster was efficiently reduced by biological thiols including L-cysteine, 
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glutathione and N-acetyl-L-cysteine, as well as dithiothreitol and the E. coli thioredoxin / 
thioredoxin reductase system. This is a novel mechanism of iron-sulfur cluster reduction and is 
reversible, as hydrogen peroxide transiently oxidized the clusters in vitro and in vivo. The thiol-
mediated reduction of mitoNEET [2Fe-2S] clusters was disrupted by pioglitazone binding to the 
protein, likely due to the concomitant decrease in the [2Fe-2S] redox midpoint potential. 
Because the reduction of mitoNEET [2Fe-2S] clusters could be facilitated by E. coli cell 
extracts with NADPH or E. coli thioredoxin reductase with NADPH, we speculated that there may 
be human proteins that enzymatically reduce mitoNEET. We found that cytoplasmic human 
glutathione reductase (hGSR) is capable of reducing the mitoNEET [2Fe-2S] clusters in an 
NADPH-dependent manner. Oxidized glutathione can compete against the mitoNEET [2Fe-2S] 
clusters for reduction by hGSR, and N-ethylmaleimide (NEM) modification of the active site 
abolished the hGSR activity to reduce the mitoNEET [2Fe-2S] clusters. These results correlated 
with those obtained using mouse heart cell extracts, which could reduce the mitoNEET [2Fe-2S] 
clusters in the presence of NADPH but failed to do so after pre-treatment with NEM. MitoNEET 
[2Fe-2S] clusters in the mouse heart cell extracts could be transiently oxidized by hydrogen 
peroxide. Taken together, these results demonstrate that mitoNEET may act as a sensor of 
intracellular redox status. 
Based on the current findings, it would be of interest to investigate [2Fe-2S] redox 
transitions in membrane-bound mitoNEET which is more representative of its native state. We 
have recently constructed a hybrid of mitoNEET fused to an E. coli membrane domain to allow 
recombinant expression of mitoNEET that mimics its native state. The fusion protein is predicted 
to have similar redox properties as the truncated protein, but it may have a stronger affinity for 
pioglitazone, as the drug is hydrophobic and may have favorable interactions with membrane-
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bound mitoNEET. Several membrane-associated proteins have also been observed to interact with 
mitoNEET (12-16); thus, membrane-bound mitoNEET may also improve the quality of protein 
interaction studies. We speculate that the redox state of mitoNEET may influence the functions 
these binding partners to constitute a novel redox signaling mechanism, and pioglitazone binding 
to mitoNEET may disrupt this communication to produce its antidiabetic effects. 
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